| Year |
Citation |
Score |
| 2024 |
Kotsopoulos J, Gronwald J, Huzarski T, Møller P, Pal T, McCuaig JM, Singer CF, Karlan BY, Aeilts A, Eng C, Eisen A, Bordeleau L, Foulkes WD, Tung N, Couch FJ, ... ... Narod SA, et al. Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology. PMID 38421677 DOI: 10.1001/jamaoncol.2023.6937 |
0.48 |
|
| 2024 |
Lubinski J, Kotsopoulos J, Moller P, Pal T, Eisen A, Peck L, Karlan BY, Aeilts A, Eng C, Bordeleau L, Foulkes WD, Tung N, Couch FJ, Fruscio R, Ramon Y Cajal T, ... ... Narod SA, et al. MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology. PMID 38421676 DOI: 10.1001/jamaoncol.2023.6944 |
0.57 |
|
| 2023 |
Narod SA. Choices for cancer prevention for women with a BRCA1 mutation? a personal view. Hereditary Cancer in Clinical Practice. 21: 26. PMID 38031144 DOI: 10.1186/s13053-023-00271-3 |
0.584 |
|
| 2023 |
Metcalfe K, Huzarski T, Gronwald J, Kotsopoulos J, Kim R, Moller P, Pal T, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Olopade O, Zakalik D, Singer CF, ... ... Narod SA, et al. Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. British Journal of Cancer. PMID 38030749 DOI: 10.1038/s41416-023-02503-8 |
0.732 |
|
| 2023 |
Guyonnet E, Kim SJ, Xia YY, Giannakeas V, Lubinski J, Randall Armel S, Eisen A, Bordeleau L, Eng C, Olopade OI, Tung N, Foulkes WD, Couch FJ, Aeilts AM, Narod SA, et al. Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation. Cancer Research Communications. 3: 2420-2429. PMID 38019076 DOI: 10.1158/2767-9764.CRC-23-0223 |
0.36 |
|
| 2023 |
Park SS, Zaman T, Kim SJ, Brooks JD, Wong AK, Lubinski J, Narod SA, Salmena L, Kotsopoulos J. Correlates of circulating osteoprotegerin in women with a pathogenic or likely pathogenic variant in the BRCA1 gene. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 38015775 DOI: 10.1158/1055-9965.EPI-23-0577 |
0.491 |
|
| 2023 |
Zamani N, Szymiczek A, Shakeri R, Poustchi H, Pourshams A, Narod S, Malekzadeh R, Akbari MR. A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers. Plos One. 18: e0292611. PMID 37943872 DOI: 10.1371/journal.pone.0292611 |
0.352 |
|
| 2023 |
Zhu JW, Wong F, Szymiczek A, Ene GEV, Zhang S, May T, Narod SA, Kotsopoulos J, Akbari MR. Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer. International Journal of Molecular Sciences. 24. PMID 37762691 DOI: 10.3390/ijms241814388 |
0.347 |
|
| 2023 |
Lim DW, Li WW, Giannakeas V, Cil TD, Narod SA. Survival of Filipino women with breast cancer in the United States. Cancer Medicine. PMID 37755311 DOI: 10.1002/cam4.6403 |
0.505 |
|
| 2023 |
Narod SA, Dent R. Triple-negative breast cancers. Expert Review of Anticancer Therapy. 1-3. PMID 37707344 DOI: 10.1080/14737140.2023.2257393 |
0.513 |
|
| 2023 |
Metcalfe KA, Pal T, Narod SA, Armel S, Shickh S, Buckley K, Walters ST, Brennenstuhl S, Kinney AY. Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial. Cancer Medicine. PMID 37602539 DOI: 10.1002/cam4.6417 |
0.576 |
|
| 2023 |
Giannakeas V, Murji A, Lipscombe LL, Narod SA, Kotsopoulos J. Salpingectomy and the Risk of Ovarian Cancer in Ontario. Jama Network Open. 6: e2327198. PMID 37566421 DOI: 10.1001/jamanetworkopen.2023.27198 |
0.382 |
|
| 2023 |
Gliniewicz K, Kluźniak W, Wokołorczyk D, Huzarski T, Stempa K, Rudnicka H, Jakubowska A, Szwiec M, Jarkiewicz-Tretyn J, Naczk M, Kluz T, Dębniak T, Gronwald J, Lubiński J, Narod SA, et al. The c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population. Genes. 14. PMID 37510234 DOI: 10.3390/genes14071329 |
0.606 |
|
| 2023 |
Kotsopoulos J, Hathaway CA, Narod SA, Teras LR, Patel AV, Hu C, Yadav S, Couch FJ, Tworoger SS. Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 37493628 DOI: 10.1158/1055-9965.EPI-23-0041 |
0.426 |
|
| 2023 |
Kotsopoulos J, Gronwald J, Huzarski T, Aeilts A, Randall Armel S, Karlan B, Singer CF, Eisen A, Tung N, Olopade O, Bordeleau L, Eng C, Foulkes WD, Neuhausen SL, Cullinane CA, ... ... Narod SA, et al. Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Research and Treatment. 201: 257-264. PMID 37432545 DOI: 10.1007/s10549-023-06991-3 |
0.753 |
|
| 2023 |
Guyonnet E, Kim SJ, Pullella K, Zhang CXW, McCuaig JM, Armel S, Narod SA, Kotsopoulos J. Vitamin D and Calcium Supplement Use and High-Risk Breast Cancer: A Case-Control Study among and Mutation Carriers. Cancers. 15. PMID 37345127 DOI: 10.3390/cancers15102790 |
0.468 |
|
| 2023 |
Gronwald J, Cybulski C, Huzarski T, Jakubowska A, Debniak T, Lener M, Narod SA, Lubinski J. Genetic testing for hereditary breast cancer in Poland: 1998-2022. Hereditary Cancer in Clinical Practice. 21: 9. PMID 37312208 DOI: 10.1186/s13053-023-00252-6 |
0.546 |
|
| 2023 |
Sopik V, Lim D, Sun P, Narod SA. Prognosis after Local Recurrence in Patients with Early-Stage Breast Cancer Treated without Chemotherapy. Current Oncology (Toronto, Ont.). 30: 3829-3844. PMID 37185403 DOI: 10.3390/curroncol30040290 |
0.438 |
|
| 2023 |
Narod SA. Looking for and mutations in Asian women with breast cancer. Annals of Translational Medicine. 11: 292. PMID 37181338 DOI: 10.21037/atm-23-348 |
0.593 |
|
| 2023 |
Cybulski C, Zamani N, Kluźniak W, Milano L, Wokołorczyk D, Stempa K, Rudnicka H, Zhang S, Zadeh M, Huzarski T, Jakubowska A, Dębniak T, Lener M, Szwiec M, Domagała P, ... ... Narod S, et al. Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank. American Journal of Human Genetics. PMID 36977412 DOI: 10.1016/j.ajhg.2023.03.002 |
0.552 |
|
| 2023 |
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, ... ... Narod SA, et al. Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment. British Journal of Cancer. PMID 36639528 DOI: 10.1038/s41416-022-02130-9 |
0.797 |
|
| 2022 |
Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, ... ... Narod SA, et al. The risks of cancer in older women with BRCA pathogenic variants: How far have we come? Cancer. PMID 36571512 DOI: 10.1002/cncr.34615 |
0.724 |
|
| 2022 |
Metcalfe KA, Narod SA, Eisen A, Poll A, Zamani N, McCready D, Cil TD, Wright FC, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari MR. Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test? Cancer Medicine. PMID 36544278 DOI: 10.1002/cam4.5515 |
0.688 |
|
| 2022 |
Nair AG, Giannakeas V, Semple JL, Narod SA, Lim DW. Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer. Annals of Surgical Oncology. PMID 36074200 DOI: 10.1245/s10434-022-12408-0 |
0.477 |
|
| 2022 |
Nair AG, Giannakeas V, Semple JL, Narod SA, Lim DW. ASO Visual Abstract: Contemporary Trends in Breast Reconstruction Use and Impact on Survival Amongst Women with Inflammatory Breast Cancer. Annals of Surgical Oncology. PMID 36071338 DOI: 10.1245/s10434-022-12458-4 |
0.461 |
|
| 2022 |
Narod SA, Sopik V. Countercurrents: DCIS or Cancer? Why All the Confusion? Current Oncology (Toronto, Ont.). 29: 4936-4940. PMID 35877252 DOI: 10.3390/curroncol29070392 |
0.564 |
|
| 2022 |
Finch A, Clark R, Vesprini D, Lorentz J, Kim RH, Thain E, Fleshner N, Akbari MR, Cybulski C, Narod SA. An appraisal of genetic testing for prostate cancer susceptibility. Npj Precision Oncology. 6: 43. PMID 35732815 DOI: 10.1038/s41698-022-00282-8 |
0.317 |
|
| 2022 |
Mahmoodi A, Shoqafi A, Sun P, Giannakeas V, Cybulski C, Nofech-Mozes S, Masson JY, Sharma S, Samani AA, Madhusudan S, Narod SA, Akbari MR. High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival. Frontiers in Oncology. 12: 877617. PMID 35712517 DOI: 10.3389/fonc.2022.877617 |
0.453 |
|
| 2022 |
Kotsopoulos J, Zamani N, Rosen B, McLaughlin JR, Risch HA, Kim SJ, Sun P, Akbari MR, Narod SA. Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer. British Journal of Cancer. PMID 35710751 DOI: 10.1038/s41416-022-01840-4 |
0.402 |
|
| 2022 |
Kotsopoulos J, Lubiński J, Gronwald J, Menkiszak J, McCuaig J, Metcalfe K, Foulkes WD, Neuhausen SL, Sun S, Karlan BY, Eisen A, Tung N, Olopade OI, Couch FJ, Huzarski T, ... ... Narod SA, et al. Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35477169 DOI: 10.1158/1055-9965.EPI-21-1196 |
0.785 |
|
| 2022 |
Howell DM, Metcalfe K, Kong S, Stephen J, Olivotto IA, Baxter N, Friedenreich CM, Warner E, Akbari MR, McBain K, Narod S, Quan ML. Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study. Breast Cancer Research and Treatment. PMID 35462611 DOI: 10.1007/s10549-022-06576-6 |
0.704 |
|
| 2022 |
Kluźniak W, Szymiczek A, Rodrigue A, Wokołorczyk D, Rusak B, Stempa K, Huzarski T, Gronwald J, Lubiński J, Zamani N, Zhang S, Masson JY, Narod SA, Cybulski C, Akbari MR. Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2. Jco Precision Oncology. 6: e2100450. PMID 35442721 DOI: 10.1200/PO.21.00450 |
0.451 |
|
| 2022 |
Złowocka-Perłowska E, Tołoczko-Grabarek A, Narod SA, Lubiński J. Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland. Hereditary Cancer in Clinical Practice. 20: 13. PMID 35395863 DOI: 10.1186/s13053-022-00220-6 |
0.414 |
|
| 2022 |
Tomiczek-Szwiec J, Szwiec M, Falco M, Cybulski C, Wokolorczyk D, Jakubowska A, Gronwald J, Stawicka M, Godlewski D, Kilar E, Marczyk E, Siołek M, Wiśniowski R, Haus O, Sibilski R, ... ... Narod SA, et al. The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations. British Journal of Cancer. PMID 35256754 DOI: 10.1038/s41416-022-01770-1 |
0.513 |
|
| 2022 |
Cieszyńska M, Kluźniak W, Wokołorczyk D, Cybulski C, Huzarski T, Gronwald J, Falco M, Dębniak T, Jakubowska A, Derkacz R, Marciniak W, Lener M, Woronko K, Mocarz D, Baszuk P, ... ... Narod SA, et al. Risk of Second Primary Thyroid Cancer in Women with Breast Cancer. Cancers. 14. PMID 35205705 DOI: 10.3390/cancers14040957 |
0.592 |
|
| 2022 |
Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer. Annals of Surgical Oncology. PMID 35166950 DOI: 10.1245/s10434-022-11340-7 |
0.732 |
|
| 2022 |
Giannakeas V, Kotsopoulos J, Brooks JD, Cheung MC, Rosella L, Lipscombe L, Akbari MR, Austin PC, Narod SA. Platelet Count and Survival after Cancer. Cancers. 14. PMID 35158817 DOI: 10.3390/cancers14030549 |
0.348 |
|
| 2022 |
Xia YY, Gronwald J, Karlan B, Lubinski J, McCuaig JM, Brooks J, Moller P, Eisen A, Sun S, Senter L, Bordeleau L, Neuhausen SL, Singer CF, Tung N, Foulkes WD, ... ... Narod SA, et al. Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology. PMID 35063280 DOI: 10.1016/j.ygyno.2022.01.014 |
0.486 |
|
| 2022 |
Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer. Annals of Surgical Oncology. PMID 35001240 DOI: 10.1245/s10434-021-11254-w |
0.767 |
|
| 2021 |
Villarreal-Garza C, Ferrigno AS, Aranda-Gutierrez A, Frankel PH, Ruel NH, Fonseca A, Narod S, Chavarri-Guerra Y, Sifuentes E, Magallanes-Hoyos MC, Herzog J, Castillo D, Alvarez-Gomez RM, Mohar-Betancourt A, Weitzel JN. Influence of germline genotype on the survival of patients with triple-negative breast cancer. Cancer Research Communications. 1: 140-147. PMID 35875314 DOI: 10.1158/2767-9764.crc-21-0099 |
0.432 |
|
| 2021 |
Finch A, Metcalfe K, Akbari M, Friedman E, Tung N, Rosen B, Eisen A, Karlan B, Foulkes W, Neuhausen SL, Senter L, McKinnon W, Elser C, Sun P, Narod SA. The Risks of Breast and Ovarian Cancer Associated with the Ashkenazi Jewish Founder Allele BRCA2 6174delT. Clinical Genetics. PMID 34897671 DOI: 10.1111/cge.14098 |
0.78 |
|
| 2021 |
Metcalfe KA, Eisen A, Wright F, Poll A, Candib A, McCready D, Cil T, Armel S, Silberman Y, Brennenstuhl S, Narod SA. Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning. Breast Cancer Research and Treatment. 191: 631-641. PMID 34846626 DOI: 10.1007/s10549-021-06457-4 |
0.785 |
|
| 2021 |
Stempa K, Wokołorczyk D, Kluźniak W, Rogoża-Janiszewska E, Malińska K, Rudnicka H, Huzarski T, Gronwald J, Gliniewicz K, Dębniak T, Jakubowska A, Lener M, Tomiczek-Szwiec J, Domagała P, Suszynska M, ... ... Narod SA, et al. Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer? Cancers. 13. PMID 34771627 DOI: 10.3390/cancers13215464 |
0.439 |
|
| 2021 |
Szwiec M, Tomiczek-Szwiec J, Kluźniak W, Wokołorczyk D, Osowiecka K, Sibilski R, Wachowiak M, Gronwald J, Gronwald H, Lubiński J, Cybulski C, Narod SA, Huzarski T. Genetic predisposition to male breast cancer in Poland. Bmc Cancer. 21: 975. PMID 34461861 DOI: 10.1186/s12885-021-08718-3 |
0.58 |
|
| 2021 |
Kim SJ, Lubiński J, Huzarski T, Møller P, Armel S, Karlan BY, Senter L, Eisen A, Foulkes WD, Singer CF, Tung N, Bordeleau L, Neuhausen SL, Olopade OI, Eng C, ... ... Narod SA, et al. Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34426412 DOI: 10.1158/1055-9965.EPI-21-0296 |
0.44 |
|
| 2021 |
Giannakeas V, Narod SA. Incidence of Cancer Among Adults With Thrombocytosis in Ontario, Canada. Jama Network Open. 4: e2120633. PMID 34383058 DOI: 10.1001/jamanetworkopen.2021.20633 |
0.375 |
|
| 2021 |
Marciniak W, Matoušek T, Domchek S, Paradiso A, Patruno M, Irmejs A, Roderte I, Derkacz R, Baszuk P, Kuświk M, Cybulski C, Huzarski T, Gronwald J, Dębniak T, Falco M, ... ... Narod S, et al. Blood Arsenic Levels as a Marker of Breast Cancer Risk among Carriers. Cancers. 13. PMID 34283078 DOI: 10.3390/cancers13133345 |
0.567 |
|
| 2021 |
Narod SA. Adjuvant olaparib - should all patients with breast cancer have genetic testing? Nature Reviews. Clinical Oncology. PMID 34282304 DOI: 10.1038/s41571-021-00544-7 |
0.479 |
|
| 2021 |
Clark R, Kenk M, McAlpine K, Thain E, Farncombe KM, Pritchard CC, Nussbaum R, Wyatt AW, de Bono J, Vesprini D, Bombard Y, Lorentz J, Narod S, Kim R, Fleshner N. The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre International Retreat. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 34171218 DOI: 10.5489/cuaj.7383 |
0.333 |
|
| 2021 |
Giannakeas V, Lim DW, Narod SA. The risk of contralateral breast cancer: a SEER-based analysis. British Journal of Cancer. PMID 34040177 DOI: 10.1038/s41416-021-01417-7 |
0.546 |
|
| 2021 |
Wokołorczyk D, Kluźniak W, Stempa K, Rusak B, Huzarski T, Gronwald J, Gliniewicz K, Kashyap A, Morawska S, Dębniak T, Jakubowska A, Szwiec M, Domagała P, Lubiński J, Narod SA, et al. PALB2 mutations and prostate cancer risk and survival. British Journal of Cancer. PMID 34006922 DOI: 10.1038/s41416-021-01410-0 |
0.345 |
|
| 2021 |
Narod SA, Gojska N, Sun P, Tryon A, Kotsopoulos J, Metcalfe K, Akbari MR. The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada. Cancers. 13. PMID 33920818 DOI: 10.3390/cancers13081894 |
0.731 |
|
| 2021 |
Szwiec M, Marciniak W, Derkacz R, Huzarski T, Gronwald J, Cybulski C, Dębniak T, Jakubowska A, Lener M, Falco M, Kładny J, Baszuk P, Duszyński J, Kotsopoulos J, Narod SA, et al. Serum Selenium Level Predicts 10-Year Survival after Breast Cancer. Nutrients. 13. PMID 33809461 DOI: 10.3390/nu13030953 |
0.453 |
|
| 2021 |
Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T, Wright F, Demsky R, Mancuso T, Sun P, Narod SA. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result. Annals of Surgical Oncology. PMID 33761021 DOI: 10.1245/s10434-021-09855-6 |
0.792 |
|
| 2021 |
Łukomska A, Menkiszak J, Gronwald J, Tomiczek-Szwiec J, Szwiec M, Jasiówka M, Blecharz P, Kluz T, Stawicka-Niełacna M, Mądry R, Białkowska K, Prajzendanc K, Kluźniak W, Cybulski C, Dębniak T, ... ... Narod SA, et al. Recurrent Mutations in , , , and in Polish Patients with Ovarian Cancer. Cancers. 13. PMID 33670479 DOI: 10.3390/cancers13040849 |
0.45 |
|
| 2021 |
George SHL, Donenberg T, Alexis C, DeGennaro V, Dyer H, Yin S, Ali J, Butler R, Chin SN, Curling D, Lowe D, Lunn J, Turnquest T, Wharfe G, Cerbon D, ... ... Narod SA, et al. Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean. Jama Network Open. 4: e210307. PMID 33646313 DOI: 10.1001/jamanetworkopen.2021.0307 |
0.512 |
|
| 2021 |
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, ... ... Narod SA, et al. Survival from breast cancer in women with a BRCA2 mutation by treatment. British Journal of Cancer. PMID 33597716 DOI: 10.1038/s41416-020-01164-1 |
0.781 |
|
| 2021 |
Pujol P, Barberis M, Beer P, Friedman E, Piulats JM, Capoluongo ED, Garcia Foncillas J, Ray-Coquard I, Penault-Llorca F, Foulkes WD, Turnbull C, Hanson H, Narod S, Arun BK, Aapro MS, et al. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. European Journal of Cancer (Oxford, England : 1990). 146: 30-47. PMID 33578357 DOI: 10.1016/j.ejca.2020.12.023 |
0.457 |
|
| 2021 |
Lim DW, Metcalfe KA, Narod SA. Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review. Jama Surgery. PMID 33566074 DOI: 10.1001/jamasurg.2020.6664 |
0.776 |
|
| 2021 |
Narod SA. Which Genes for Hereditary Breast Cancer? The New England Journal of Medicine. PMID 33471975 DOI: 10.1056/NEJMe2035083 |
0.502 |
|
| 2021 |
Stjepanovic N, Lubinski J, Moller P, Randall Armel S, Foulkes WD, Tung N, Neuhausen SL, Kotsopoulos J, Sun P, Sun S, Eisen A, Narod SA. Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. PMID 33423179 DOI: 10.1007/s10549-020-06072-9 |
0.54 |
|
| 2020 |
Kim SR, Kotsopoulos J, Sun P, Bernardini M, Laframboise S, Ferguson S, Rosen B, Narod SA, May T. The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 33326624 DOI: 10.1002/ijgo.13542 |
0.308 |
|
| 2020 |
Warner E, Zhu S, Plewes DB, Hill K, Ramsay EA, Causer PA, Seely J, Jong RA, Lenkov P, Elser C, Crystal P, Yaffe MJ, Giannakeas V, Sun P, Narod SA. Breast Cancer Mortality among Women with a or Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program. Cancers. 12. PMID 33238387 DOI: 10.3390/cancers12113479 |
0.527 |
|
| 2020 |
Metcalfe KA, Candib A, Giannakeas V, Eisen A, Poll A, McCready D, Cil T, Wright FC, Armel S, Ott K, Sun P, Narod SA. The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer. Breast Cancer Research and Treatment. PMID 33174180 DOI: 10.1007/s10549-020-05992-w |
0.769 |
|
| 2020 |
Narod SA. Mammography screening for breast cancer-the UK Age trial. The Lancet. Oncology. 21: e508. PMID 33152300 DOI: 10.1016/S1470-2045(20)30490-3 |
0.419 |
|
| 2020 |
Narod SA, Giannakeas V. In Response to "Pregnancy After Breast Cancer in Patients With Germline Mutations". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002253. PMID 33125308 DOI: 10.1200/JCO.20.02253 |
0.501 |
|
| 2020 |
Lim DW, Giannakeas V, Narod SA. Survival Differences in Chinese Versus White Women With Breast Cancer in the United States: A SEER-Based Analysis. Jco Global Oncology. 6: 1582-1592. PMID 33079607 DOI: 10.1200/GO.20.00316 |
0.504 |
|
| 2020 |
Mansfield CA, Metcalfe KA, Snyder C, Lindeman GJ, Posner J, Friedman S, Lynch HT, Narod SA, Evans DG, Liede A. Preferences for breast cancer prevention among women with a or mutation. Hereditary Cancer in Clinical Practice. 18: 20. PMID 33014209 DOI: 10.1186/s13053-020-00152-z |
0.815 |
|
| 2020 |
Kotsopoulos J, Gronwald J, McCuaig JM, Karlan BY, Eisen A, Tung N, Bordeleau L, Senter L, Eng C, Couch F, Fruscio R, Weitzel JN, Olopade O, Singer CF, Pal T, ... ... Narod SA, et al. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology. PMID 33010967 DOI: 10.1016/j.ygyno.2020.09.037 |
0.526 |
|
| 2020 |
Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T, Wright F, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari M, Narod SA. Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study. Annals of Surgical Oncology. PMID 32989658 DOI: 10.1245/s10434-020-09160-8 |
0.81 |
|
| 2020 |
Olafsdottir EJ, Borg A, Jensen MB, Gerdes AM, Johansson ALV, Barkardottir RB, Johannsson OT, Ejlertsen B, Sønderstrup IMH, Hovig E, Lænkholm AV, Hansen TVO, Olafsdottir GH, Rossing M, Jonasson JG, ... ... Narod SA, et al. Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status. British Journal of Cancer. PMID 32939053 DOI: 10.1038/S41416-020-01056-4 |
0.609 |
|
| 2020 |
Giannakeas V, Sopik V, Narod SA. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer. Jama Network Open. 3: e2017124. PMID 32936299 DOI: 10.1001/jamanetworkopen.2020.17124 |
0.542 |
|
| 2020 |
Wokołorczyk D, Kluźniak W, Huzarski T, Gronwald J, Szymiczek A, Rusak B, Stempa K, Gliniewicz K, Kashyap A, Morawska S, Dębniak T, Jakubowska A, Szwiec M, Domagała P, Lubiński J, ... Narod SA, et al. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. International Journal of Cancer. PMID 32875559 DOI: 10.1002/Ijc.33272 |
0.49 |
|
| 2020 |
Rogoża-Janiszewska E, Malińska K, Cybulski C, Jakubowska A, Gronwald J, Huzarski T, Lener M, Górski B, Kluźniak W, Rudnicka H, Akbari MR, Kashyap A, Narod SA, Lubiński J, Dębniak T, et al. Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland. Cancers. 12. PMID 32824581 DOI: 10.3390/Cancers12082321 |
0.657 |
|
| 2020 |
Bagherzadeh M, Szymiczek A, Donenberg T, Butler R, Hurley J, Narod SA, Akbari MR. Association of RAD51C germline mutations with breast cancer among Bahamians. Breast Cancer Research and Treatment. PMID 32809180 DOI: 10.1007/S10549-020-05872-3 |
0.654 |
|
| 2020 |
Mejia-Gomez J, Gronwald J, Senter L, Karlan BY, Tung N, Wolfman W, Demsky R, Sun P, Narod SA, Kotsopoulos J. Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers. Menopause (New York, N.Y.). PMID 32796289 DOI: 10.1097/Gme.0000000000001629 |
0.393 |
|
| 2020 |
Lim DW, Narod SA. Outcomes of breast reconstruction following prophylactic bilateral mastectomy. The Breast Journal. PMID 32783312 DOI: 10.1111/Tbj.14016 |
0.414 |
|
| 2020 |
Metcalfe KA, Price MA, Mansfield C, Hallett DC, Lindeman GJ, Fairchild A, Posner J, Friedman S, Snyder C, Lynch HT, Evans DG, Narod SA, Liede A. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis. British Journal of Cancer. PMID 32393849 DOI: 10.1038/S41416-020-0861-3 |
0.811 |
|
| 2020 |
Sopik V, Giannakeas V, Narod S. Letter to the Editor: Radiation for Prior DCIS is a Risk Factor for Death From Invasive Breast Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 18: xliiia. PMID 32380468 DOI: 10.6004/Jnccn.2020.7531 |
0.531 |
|
| 2020 |
Kotsopoulos J, Karlan B, Gronwald J, Hall E, Moller P, Tung N, Zakalik D, Foulkes WD, Rosen B, Neuhausen SL, Sun P, Lubinksi J, Narod SA. Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among and mutation carriers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 32354794 DOI: 10.1136/Ijgc-2019-001141 |
0.579 |
|
| 2020 |
Kotsopoulos J, McGee EE, Lozano-Esparza S, Garber JE, Ligibel J, Collins LC, Polyak K, Brown M, Narod S, Tamimi RM, Eliassen AH. Premenopausal plasma osteoprotegerin and breast cancer risk: a case-control analysis nested within the Nurses' Health Study II. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32277005 DOI: 10.1158/1055-9965.Epi-19-1154 |
0.521 |
|
| 2020 |
Kotsopoulos J, Narod SA. Prophylactic salpingectomy for the prevention of ovarian cancer; who should we target? International Journal of Cancer. PMID 32037528 DOI: 10.1002/Ijc.32916 |
0.561 |
|
| 2020 |
Sanchez-Covarrubias A, Cerbon D, Barreto Coelho P, Donenberg T, Akbari MR, Ali J, Butler R, Curling D, Dodds L, DeGennaro VA, Dyer H, Halliday DAC, Narod S, Reis IN, Schlumbrecht M, et al. Reproductive risk factor patterns in the Caribbean affecting breast cancer age of onset. Journal of Clinical Oncology. 38: e13632-e13632. DOI: 10.1200/Jco.2020.38.15_Suppl.E13632 |
0.593 |
|
| 2020 |
George SHL, Donenberg T, Alexis C, DeGennaro V, Dyer H, Yin S, Barreto-Coelho P, Thompson S, Butler R, Wharfe G, Ali J, Turnquest T, Curling D, Akbari M, Narod S, et al. Abstract C060: The spectrum of germline mutation carriers in a cohort of breast and ovarian cancer patients in the Caribbean Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-C060 |
0.605 |
|
| 2020 |
Giannakeas V, Narod SA. Abstract P5-07-07: A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumor dormancy Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-07-07 |
0.465 |
|
| 2019 |
Narod SA, Huzarski T, Jakubowska A, Gronwald J, Cybulski C, Oszurek O, Dębniak T, Jaworska-Bieniek K, Lener M, Białkowska K, Sukiennicki G, Muszyńska M, Marciniak W, Sun P, Kotsopoulos J, et al. Serum selenium level and cancer risk: a nested case-control study. Hereditary Cancer in Clinical Practice. 17: 33. PMID 31890061 DOI: 10.1186/S13053-019-0131-7 |
0.49 |
|
| 2019 |
Narod SA, Giannakeas V, Sopik V. Late Recurrences After Estrogen Receptor-Positive Breast Cancer. Jama Oncology. PMID 31830232 DOI: 10.1001/Jamaoncol.2019.5579 |
0.535 |
|
| 2019 |
Lerner-Ellis J, Sopik V, Wong A, Lázaro C, Narod SA, Charames GS. Retesting of women who are negative for a and mutation using a 20-gene panel. Journal of Medical Genetics. PMID 31784482 DOI: 10.1136/Jmedgenet-2019-106403 |
0.584 |
|
| 2019 |
Glentis S, Dimopoulos AC, Rouskas K, Ntritsos G, Evangelou E, Narod SA, Mes-Masson AM, Foulkes WD, Rivera B, Tonin PN, Ragoussis J, Dimas AS. Exome Sequencing in and -Negative Greek Families Identifies and as Candidate Risk Genes for Hereditary Breast Cancer. Frontiers in Genetics. 10: 1005. PMID 31681433 DOI: 10.3389/Fgene.2019.01005 |
0.562 |
|
| 2019 |
Warner E, Yee S, Seminsky M, Glass K, Foong S, Kennedy E, Narod S, Quan ML. Effect of a Knowledge-Translation Intervention on Breast Surgeons' Oncofertility Attitudes and Practices. Annals of Surgical Oncology. PMID 31659644 DOI: 10.1245/S10434-019-07972-X |
0.498 |
|
| 2019 |
Kotsopoulos J, Gronwald J, Lubinski J, McCuaig J, Lynch HT, Neuhausen SL, Foulkes WD, Weitzel JN, Senter L, Tung N, Eng C, Karlan B, Sun P, Narod SA. Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers? Menopause (New York, N.Y.). PMID 31644510 DOI: 10.1097/Gme.0000000000001437 |
0.515 |
|
| 2019 |
Kluźniak W, Wokołorczyk D, Rusak B, Huzarski T, Kashyap A, Stempa K, Rudnicka H, Jakubowska A, Szwiec M, Morawska S, Gliniewicz K, Mordak K, Stawicka M, Jarkiewicz-Tretyn J, Cechowska M, ... ... Narod SA, et al. Inherited Variants in and the Risk and Clinical Characteristics of Breast Cancer. Cancers. 11. PMID 31614901 DOI: 10.3390/Cancers11101548 |
0.664 |
|
| 2019 |
Gronwald J, Lubinski J, Huzarski T, Cybulski C, Menkiszak J, Siołek M, Stawicka M, Sun P, Kim S, Kotsopoulos J, Narod SA. A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy. Gynecologic Oncology. PMID 31500890 DOI: 10.1016/J.Ygyno.2019.08.034 |
0.538 |
|
| 2019 |
Narod SA. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc). The Lancet. Oncology. 20: e465. PMID 31486364 DOI: 10.1016/S1470-2045(19)30489-9 |
0.589 |
|
| 2019 |
Prajzendanc K, Domagała P, Hybiak J, Ryś J, Huzarski T, Szwiec M, Tomiczek-Szwiec J, Redelbach W, Sejda A, Gronwald J, Kluz T, Wiśniowski R, Cybulski C, Łukomska A, Białkowska K, ... ... Narod SA, et al. BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer. International Journal of Cancer. PMID 31469414 DOI: 10.1002/Ijc.32655 |
0.536 |
|
| 2019 |
Kluźniak W, Wokołorczyk D, Rusak B, Huzarski T, Gronwald J, Stempa K, Rudnicka H, Kashyap A, Dębniak T, Jakubowska A, Lener M, Szwiec M, Tomiczek-Szwiec J, Jarkiewicz-Tretyn J, Cechowska M, ... ... Narod SA, et al. Inherited variants in XRCC2 and the risk of breast cancer. Breast Cancer Research and Treatment. PMID 31463769 DOI: 10.1007/S10549-019-05415-5 |
0.599 |
|
| 2019 |
Cerretini R, Mercado G, Morganstein J, Schiaffi J, Reynoso M, Montoya D, Valdéz R, Narod SA, Akbari MR. Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina. Breast Cancer Research and Treatment. PMID 31446535 DOI: 10.1007/S10549-019-05411-9 |
0.665 |
|
| 2019 |
Rusak B, Kluźniak W, Wokołorczyk D, Stempa K, Kashyap A, Rudnicka H, Gronwald J, Huzarski T, Dębniak T, Jakubowska A, Szwiec M, Akbari MR, Narod SA, Lubiński J, Cybulski C, et al. Allelic modification of breast cancer risk in women with an NBN mutation. Breast Cancer Research and Treatment. PMID 31410679 DOI: 10.1007/S10549-019-05391-W |
0.626 |
|
| 2019 |
Marciniak W, Derkacz R, Muszyńska M, Baszuk P, Gronwald J, Huzarski T, Cybulski C, Jakubowska A, Falco M, Dębniak T, Lener M, Oszurek O, Pullella K, Kotsopoulos J, Sun P, ... Narod SA, et al. Blood Arsenic Levels and the Risk of Familial Breast Cancer in Poland. International Journal of Cancer. PMID 31348523 DOI: 10.1002/Ijc.32595 |
0.605 |
|
| 2019 |
Giannakeas V, Narod SA. A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy. Breast Cancer Research and Treatment. PMID 31264063 DOI: 10.1007/S10549-019-05334-5 |
0.575 |
|
| 2019 |
Moran O, Eisen A, Demsky R, Blackmore K, Knight JA, Panchal S, Ginsburg O, Zbuk K, Yaffe M, Metcalfe KA, Narod SA, Kotsopoulos J. Predictors of mammographic density among women with a strong family history of breast cancer. Bmc Cancer. 19: 631. PMID 31242899 DOI: 10.1186/S12885-019-5855-2 |
0.793 |
|
| 2019 |
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, ... ... Narod SA, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 31211375 DOI: 10.1093/Ije/Dyz113 |
0.493 |
|
| 2019 |
Narod SA. Genetic testing for breast cancer in the Hispanic community. Cancer. PMID 31206622 DOI: 10.1002/Cncr.32334 |
0.536 |
|
| 2019 |
Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Kashyap A, Rusak B, Stempa K, Gronwald J, Szymiczek A, Bagherzadeh M, Jakubowska A, Dębniak T, Lener M, Rudnicka H, Szwiec M, ... ... Narod SA, et al. The Spectrum of Mutations Predisposing to Familial Breast Cancer in Poland. International Journal of Cancer. PMID 31173646 DOI: 10.1002/Ijc.32492 |
0.662 |
|
| 2019 |
Narod SA. Is bilateral radiation an option for BRCA mutation carriers with unilateral breast cancer? Annals of Translational Medicine. 7: 165. PMID 31168446 DOI: 10.21037/Atm.2019.03.27 |
0.645 |
|
| 2019 |
Suszynska M, Kluzniak W, Wokolorczyk D, Jakubowska A, Huzarski T, Gronwald J, Debniak T, Szwiec M, Ratajska M, Klonowska K, Narod S, Bogdanova N, Dörk T, Lubinski J, Cybulski C, et al. is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation. Cancers. 11. PMID 31142030 DOI: 10.3390/Cancers11060740 |
0.544 |
|
| 2019 |
Zaman T, Sun P, Narod SA, Salmena L, Kotsopoulos J. Plasma RANKL levels are not associated with breast cancer risk in and mutation carriers. Oncotarget. 10: 2475-2483. PMID 31069010 DOI: 10.18632/Oncotarget.26810 |
0.643 |
|
| 2019 |
Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, ... ... Narod SA, et al. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. British Journal of Cancer. PMID 30971774 DOI: 10.1038/S41416-019-0446-1 |
0.808 |
|
| 2019 |
Reid BM, Permuth JB, Chen YA, Fridley BL, Iversen ES, Chen Z, Jim H, Vierkant RA, Cunningham JM, Barnholtz-Sloan JS, Narod S, Risch H, Schildkraut JM, Goode EL, Monteiro AN, et al. Genome-wide analysis of common copy number variation and epithelial ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30948450 DOI: 10.1158/1055-9965.Epi-18-0833 |
0.438 |
|
| 2019 |
Zlowocka-Perlowska E, Narod SA, Cybulski C. CHEK2 Alleles Predispose to Renal Cancer in Poland. Jama Oncology. PMID 30816943 DOI: 10.1001/Jamaoncol.2019.0022 |
0.391 |
|
| 2019 |
Narod SA. Author response to "a response to 'personalised medicine and population health: breast and ovarian cancer'". Human Genetics. PMID 30790050 DOI: 10.1007/S00439-019-01981-2 |
0.471 |
|
| 2019 |
Kotsopoulos J, Lubinski J, Lynch HT, Tung N, Armel S, Senter L, Singer CF, Fruscio R, Couch F, Weitzel JN, Karlan B, Foulkes WD, Moller P, Eisen A, Ainsworth P, ... ... Narod SA, et al. Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. PMID 30756284 DOI: 10.1007/S10549-019-05162-7 |
0.66 |
|
| 2019 |
Giannakeas V, Narod SA. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. PMID 30748004 DOI: 10.1002/Cncr.32008 |
0.544 |
|
| 2019 |
Metcalfe K, Lynch HT, Foulkes WD, Tung N, Olopade OI, Eisen A, Lerner-Ellis J, Snyder C, Kim SJ, Sun P, Narod SA. Oestrogen receptor status and survival in women with BRCA2-associated breast cancer. British Journal of Cancer. PMID 30723304 DOI: 10.1038/S41416-019-0376-Y |
0.812 |
|
| 2019 |
Narod S. Association Between Invasive Lobular Breast Cancer and Mutations in the Mismatch Repair Gene MSH6. Jama Oncology. 5: 120. PMID 30629137 DOI: 10.1001/Jamaoncol.2018.6908 |
0.6 |
|
| 2019 |
Lubinski J, Huzarski T, Gronwald J, Cybulski C, Debniak T, Sun P, Kim SJ, Kotsopoulos J, Narod SA. Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriers. Breast Cancer Research and Treatment. PMID 30612273 DOI: 10.1007/S10549-018-05076-W |
0.668 |
|
| 2019 |
Kim SJ, Zhang CXW, Demsky R, Armel S, Kim YI, Narod SA, Kotsopoulos J. Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case-control study. Breast Cancer Research and Treatment. PMID 30603998 DOI: 10.1007/S10549-018-05118-3 |
0.584 |
|
| 2019 |
Narod S, Sopik V, Cybulski C. Testing Ashkenazi Jewish Women for Mutations Predisposing to Breast Cancer in Genes Other Than BRCA1 and BRCA2. Jama Oncology. 4: 1012. PMID 29801022 DOI: 10.1001/Jamaoncol.2018.0595 |
0.648 |
|
| 2019 |
Warner E, Yee S, Seminsky M, Lipson D, Glass K, Foong S, Kennedy ED, Narod S, Quan ML. Barriers to fertility preservation (FP) in a prospective pan-Canadian study of young women with breast cancer (YWBC). Journal of Clinical Oncology. 37: 136-136. DOI: 10.1200/Jco.2019.37.27_Suppl.136 |
0.484 |
|
| 2019 |
Metcalfe KA, Poll A, Eisen A, Lerner-Ellis J, Narod S. Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis. Journal of Clinical Oncology. 37: 1577-1577. DOI: 10.1200/Jco.2019.37.15_Suppl.1577 |
0.785 |
|
| 2018 |
Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. Jama Network Open. 1: e181100. PMID 30646103 DOI: 10.1001/jamanetworkopen.2018.1100 |
0.386 |
|
| 2018 |
Rusak B, Kluźniak W, Wokołorczyk D, Stempa K, Kashyap A, Gronwald J, Huzarski T, Dębniak T, Jakubowska A, Masojć B, Akbari MR, Narod SA, Lubiński J, Cybulski C. Inherited NBN Mutations and Prostate Cancer Risk and Survival. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30590007 DOI: 10.4143/crt.2018.532 |
0.367 |
|
| 2018 |
Garbens A, Wallis CJD, Matta R, Kodama R, Herschorn S, Narod S, Nam RK. The cost of treatment and its related complications for men who receive surgery or radiation therapy for prostate cancer. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 30526806 DOI: 10.5489/Cuaj.5598 |
0.314 |
|
| 2018 |
Donenberg T, George S, Ali J, Bravo G, Hernandez K, Sookar N, Ashing KT, Narod SA, Akbari MR, Hurley J. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families. Breast Cancer Research and Treatment. PMID 30515680 DOI: 10.1007/S10549-018-5045-Y |
0.601 |
|
| 2018 |
Hilsden RJ, Heitman SJ, Mizrahi B, Narod SA, Goshen R. Prediction of findings at screening colonoscopy using a machine learning algorithm based on complete blood counts (ColonFlag). Plos One. 13: e0207848. PMID 30481208 DOI: 10.1371/Journal.Pone.0207848 |
0.386 |
|
| 2018 |
Giannakeas V, Cadarette SM, Ban JK, Lipscombe L, Narod SA, Kotsopoulos J. Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study. British Journal of Cancer. PMID 30420611 DOI: 10.1038/S41416-018-0225-4 |
0.58 |
|
| 2018 |
Hall E, Finch A, Jacobson M, Rosen B, Metcalfe K, Sun P, Narod SA, Kotsopoulos J. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology. PMID 30414741 DOI: 10.1016/J.Ygyno.2018.10.040 |
0.697 |
|
| 2018 |
Narod SA. Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer. Jama Oncology. PMID 30383137 DOI: 10.1001/Jamaoncol.2018.4931 |
0.589 |
|
| 2018 |
Narod SA. Personalised medicine and population health: breast and ovarian cancer. Human Genetics. PMID 30328515 DOI: 10.1007/S00439-018-1944-6 |
0.584 |
|
| 2018 |
Sopik V, Sun P, Narod SA. Predictors of time to death after distant recurrence in breast cancer patients. Breast Cancer Research and Treatment. PMID 30328050 DOI: 10.1007/S10549-018-5002-9 |
0.526 |
|
| 2018 |
McGrath LJ, Overman RA, Reams D, Cetin K, Liede A, Narod SA, Brookhart MA, Hernandez RK. Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US. Clinical Epidemiology. 10: 1349-1358. PMID 30288124 DOI: 10.2147/Clep.S175063 |
0.449 |
|
| 2018 |
Visvanathan K, Shaw P, May BJ, Bahadirli-Talbot A, Kaushiva A, Risch H, Narod S, Wang TL, Parkash V, Vang R, Levine DA, Soslow R, Kurman R, Shih IM. Fallopian tube lesions in women at high risk for ovarian cancer: A multicenter study. Cancer Prevention Research (Philadelphia, Pa.). PMID 30232083 DOI: 10.1158/1940-6207.Capr-18-0009 |
0.457 |
|
| 2018 |
Ahmed H, Lerner-Ellis J, Cybulski C, Metcalfe K, Lubiński J, Narod SA, Akbari MR. Reply to 'Mutations in RECQL are not associated with breast cancer risk in an Australian population'. Nature Genetics. PMID 30224648 DOI: 10.1038/S41588-018-0233-6 |
0.777 |
|
| 2018 |
Narod SA, Giannakeas V, Sopik V. Time to death in breast cancer patients as an indicator of treatment response. Breast Cancer Research and Treatment. PMID 30168014 DOI: 10.1007/S10549-018-4935-3 |
0.515 |
|
| 2018 |
Ginsburg O, Narod SA. Clinical Cancer Genetics in a Lower-Middle Income Country: Considerations for Policymaking. Journal of Global Oncology. 1-3. PMID 30084717 DOI: 10.1200/Jgo.18.00081 |
0.402 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Narod SA, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.378 |
|
| 2018 |
Jerzak KJ, Cockburn JG, Dhesy-Thind SK, Pond GR, Pritchard KI, Nofech-Mozes S, Sun P, Narod SA, Bane A. Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study. Breast Cancer Research and Treatment. PMID 29915948 DOI: 10.1007/S10549-018-4844-5 |
0.556 |
|
| 2018 |
Kotsopoulos J, Gronwald J, Karlan B, Rosen B, Huzarski T, Moller P, Lynch HT, Singer CF, Senter L, Neuhausen SL, Tung N, Eisen A, Foulkes WD, Ainsworth P, Sun P, ... ... Narod SA, et al. Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology. PMID 29793803 DOI: 10.1016/J.Ygyno.2018.05.011 |
0.48 |
|
| 2018 |
Kotsopoulos J, Gronwald J, Lynch HT, Eisen A, Neuhausen SL, Tung N, Ainsworth P, Weitzel JN, Pal T, Foulkes WD, Eng C, Singer CF, Senter L, Sun P, Lubinski J, ... Narod SA, et al. Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. PMID 29774471 DOI: 10.1007/S10549-018-4822-Y |
0.625 |
|
| 2018 |
Kotsopoulos J, Gronwald J, Karlan BY, Huzarski T, Tung N, Moller P, Armel S, Lynch HT, Senter L, Eisen A, Singer CF, Foulkes WD, Jacobson MR, Sun P, Lubinski J, ... Narod SA, et al. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers. Jama Oncology. PMID 29710224 DOI: 10.1001/Jamaoncol.2018.0211 |
0.631 |
|
| 2018 |
Sopik V, Narod SA. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Research and Treatment. PMID 29693227 DOI: 10.1007/S10549-018-4796-9 |
0.507 |
|
| 2018 |
Moran O, Zaman T, Eisen A, Demsky R, Blackmore K, Knight JA, Elser C, Ginsburg O, Zbuk K, Yaffe M, Narod SA, Salmena L, Kotsopoulos J. Serum osteoprotegerin levels and mammographic density among high-risk women. Cancer Causes & Control : Ccc. PMID 29679262 DOI: 10.1007/S10552-018-1035-Y |
0.531 |
|
| 2018 |
Metcalfe K, Akbari MR, Narod SA. Genetic testing for young women with breast cancer. The Lancet. Oncology. 19: e182. PMID 29611519 DOI: 10.1016/S1470-2045(18)30162-1 |
0.8 |
|
| 2018 |
Wallis CJD, Morton G, Herschorn S, Kodama RT, Kulkarni GS, Appu S, Shayegan B, Buckley R, Grabowski A, Narod SA, Nam RK. The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation. British Journal of Cancer. PMID 29593338 DOI: 10.1038/S41416-018-0071-4 |
0.324 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Narod SA, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.465 |
|
| 2018 |
Kim SJ, Huzarski T, Gronwald J, Singer CF, Møller P, Lynch HT, Armel S, Karlan BY, Foulkes WD, Neuhausen SL, Senter L, Eisen A, Eng C, Panchal S, Pal T, ... ... Narod SA, et al. Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers. International Journal of Epidemiology. PMID 29547931 DOI: 10.1093/Ije/Dyy039 |
0.612 |
|
| 2018 |
Narod SA. Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass? Breast Cancer Research and Treatment. PMID 29541974 DOI: 10.1007/S10549-018-4739-5 |
0.546 |
|
| 2018 |
Lubiński J, Marciniak W, Muszynska M, Jaworowska E, Sulikowski M, Jakubowska A, Kaczmarek K, Sukiennicki G, Falco M, Baszuk P, Mojsiewicz M, Kotsopoulos J, Sun P, Narod SA, Lubiński JA. Correction: Serum selenium levels and the risk of progression of laryngeal cancer. Plos One. 13: e0194469. PMID 29529076 DOI: 10.1371/Journal.Pone.0194469 |
0.369 |
|
| 2018 |
Kluz T, Jasiewicz A, Marczyk E, Jach R, Jakubowska A, Lubiński J, Narod SA, Gronwald J. Frequency ofandcausative founder variants in ovarian cancer patients in South-East Poland. Hereditary Cancer in Clinical Practice. 16: 6. PMID 29492181 DOI: 10.1186/S13053-018-0089-X |
0.553 |
|
| 2018 |
Narod SA. Is There a Future for Ovarian Cancer Screening? Jama Internal Medicine. PMID 29450456 DOI: 10.1001/Jamainternmed.2018.0591 |
0.44 |
|
| 2018 |
Giannakeas V, Sopik V, Narod SA. A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis. Breast Cancer Research and Treatment. PMID 29445939 DOI: 10.1007/S10549-018-4716-Z |
0.57 |
|
| 2018 |
Jacobson M, Narod SA. Does oophorectomy reduce breast cancer mortality for BRCA mutation carriers after breast cancer? Expert Review of Anticancer Therapy. PMID 29431530 DOI: 10.1080/14737140.2018.1438891 |
0.633 |
|
| 2018 |
Lammert J, Lubinski J, Gronwald J, Huzarski T, Armel S, Eisen A, Meschino WS, Lynch HT, Snyder C, Eng C, Olopade OI, Ginsburg O, Foulkes WD, Elser C, Cohen SA, ... ... Narod SA, et al. Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. PMID 29404807 DOI: 10.1007/S10549-018-4694-1 |
0.609 |
|
| 2018 |
Narod SA, Sopik V. Is invasion a necessary step for metastases in breast cancer? Breast Cancer Research and Treatment. PMID 29353366 DOI: 10.1007/S10549-017-4644-3 |
0.513 |
|
| 2018 |
Ko KP, Kim SJ, Huzarski T, Gronwald J, Lubinski J, Lynch HT, Armel S, Park SK, Karlan B, Singer CF, Neuhausen SL, Narod SA, Kotsopoulos J. The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. PMID 29330845 DOI: 10.1002/Ijc.31257 |
0.553 |
|
| 2018 |
Kotsopoulos J, Narod SA. Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial? Expert Review of Anticancer Therapy. 1-2. PMID 29308680 DOI: 10.1080/14737140.2018.1424547 |
0.553 |
|
| 2018 |
Lubiński J, Marciniak W, Muszynska M, Jaworowska E, Sulikowski M, Jakubowska A, Kaczmarek K, Sukiennicki G, Falco M, Baszuk P, Mojsiewicz M, Kotsopoulos J, Sun P, Narod SA, Lubiński JA. Serum selenium levels and the risk of progression of laryngeal cancer. Plos One. 13: e0184873. PMID 29304040 DOI: 10.1371/Journal.Pone.0184873 |
0.426 |
|
| 2018 |
Narod S, Akbari MR. Population-Based Genetic Testing for BRCA1 and BRCA2. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017758490. PMID 29293388 DOI: 10.1200/Jco.2017.75.8490 |
0.346 |
|
| 2018 |
Kotsopoulos J, Willows K, Trat S, Kim RH, Volenik A, Sun P, Narod SA, Boyd J, May T. BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 28: 69-76. PMID 29194191 DOI: 10.1097/Igc.0000000000001144 |
0.535 |
|
| 2018 |
Hall E, Kotsopoulos J, Finch A, Thompson I, Rosen B, Murphy J, Narod S, Cheung A. Impact of prophylactic bilateral salpingo-oophorectomy on bone health in BRCA mutation carriers: A prospective cohort study. Journal of Clinical Oncology. 36: 1566-1566. DOI: 10.1200/Jco.2018.36.15_Suppl.1566 |
0.53 |
|
| 2018 |
Warner E, Zhu S, Hill K, Causer P, Jong RA, Yaffe M, Ramsay E, Narod S, Plewes DB. "What if I keep my breasts?" Extended follow-up of unaffected BRCA mutation carriers diagnosed with breast cancer (BC) in the Toronto magnetic resonance imaging (MRI) screening study. Journal of Clinical Oncology. 36: 1523-1523. DOI: 10.1200/Jco.2018.36.15_Suppl.1523 |
0.533 |
|
| 2018 |
George SH, Leon AS, Donenberg T, Bulter R, Halliday D, Curling D, Turnquest T, Lunn J, Akbari MR, Narod S, Hurley J. Abstract B81: Changing fertility factors affecting breast cancer in the Bahamas Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-B81 |
0.658 |
|
| 2018 |
George S, Bravo G, Sandoval A, Palacio S, Ali J, Donenberg T, Akbari, Narod S, Hurley J. Abstract P4-10-11: An active approach to genetic counseling in Trinidadian women with breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-10-11 |
0.549 |
|
| 2017 |
Wallis CJD, Akbari MR, Narod SA, Nam RK. RE: Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer. Journal of the National Cancer Institute. 109. PMID 30053076 DOI: 10.1093/jnci/djx105 |
0.317 |
|
| 2017 |
Narod SA, Butler R, Bobrowski D, Akbari MR, Curling D, Lunn J, Ho C, Panahi S, Llacuachaqui M, Donenberg T, Hurley J. Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutation. Molecular Genetics & Genomic Medicine. PMID 29266833 DOI: 10.1002/Mgg3.363 |
0.495 |
|
| 2017 |
Narod SA, Huzarski T, Gronwald J, Byrski T, Marczyk E, Cybulski C, Szwiec M, Wisniowski R, Birkenfeld B, Kilar E, Sibilski R, Sun P, Lubinski J. Predictors of survival for breast cancer patients with a BRCA1 mutation. Breast Cancer Research and Treatment. PMID 29247441 DOI: 10.1007/S10549-017-4605-X |
0.606 |
|
| 2017 |
Metcalfe KA, Lubinski J, Gronwald J, Huzarski T, McCuaig J, Lynch HT, Karlan B, Foulkes WD, Singer CF, Neuhausen SL, Senter L, Eisen A, Sun P, Narod SA. The Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers without a First-Degree Relative with Breast Cancer. Clinical Genetics. PMID 29206279 DOI: 10.1111/Cge.13191 |
0.803 |
|
| 2017 |
Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Høgdall E, Jensen A, ... ... Narod SA, et al. Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141849 DOI: 10.1158/1055-9965.Epi-17-0655 |
0.489 |
|
| 2017 |
Sopik V, Sun P, Narod SA. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ. Breast Cancer Research and Treatment. PMID 29119353 DOI: 10.1007/S10549-017-4572-2 |
0.429 |
|
| 2017 |
Narod S, Booth CM, Foulkes WD. Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer. The New England Journal of Medicine. 377: 1792. PMID 29094857 DOI: 10.1056/Nejmc1711644 |
0.638 |
|
| 2017 |
Akbari MR, Gojska N, Narod SA. Coming of age in Canada: a study of population-based genetic testing for breast and ovarian cancer Current Oncology. 24: 282-283. PMID 29089794 DOI: 10.3747/Co.24.3828 |
0.541 |
|
| 2017 |
Lubinski J, Marciniak W, Muszynska M, Huzarski T, Gronwald J, Cybulski C, Jakubowska A, Debniak T, Falco M, Kladny J, Kotsopoulos J, Sun P, Narod SA. Serum selenium levels predict survival after breast cancer. Breast Cancer Research and Treatment. PMID 29043463 DOI: 10.1007/S10549-017-4525-9 |
0.538 |
|
| 2017 |
Giannakeas V, Narod SA. The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy. Breast Cancer Research and Treatment. PMID 28914396 DOI: 10.1007/S10549-017-4476-1 |
0.561 |
|
| 2017 |
Narod SA, Ahmed H, Sopik V. Wherein the authors attempt to minimize the confusion generated by their study "Breast cancer mortality after a diagnosis of ductal carcinoma in situ" by several commentators who disagree with them and a few who don't: a qualitative study. Current Oncology (Toronto, Ont.). 24: e255-e260. PMID 28874895 DOI: 10.3747/Co.24.3626 |
0.486 |
|
| 2017 |
Narod SA. Women with cancer in low-income countries. Current Oncology (Toronto, Ont.). 24: 217-219. PMID 28874888 DOI: 10.3747/Co.24.3584 |
0.475 |
|
| 2017 |
McInerney NM, Narod S, Metcalfe K, Semple J, Brown MH. Breast Cancer Genetics for Plastic Surgeons. Plastic and Reconstructive Surgery. 140: 455-460. PMID 28841602 DOI: 10.1097/Prs.0000000000003577 |
0.717 |
|
| 2017 |
Sopik V, Narod SA. DCIS and Breast Cancer: Challenging the Paradigm. Annals of Surgery. PMID 28697051 DOI: 10.1097/Sla.0000000000002417 |
0.595 |
|
| 2017 |
Narod SA, Akbari M. Mutation Frequencies in Patients With Early-Onset Colorectal Cancer. Jama Oncology. PMID 28687833 DOI: 10.1001/jamaoncol.2017.0084 |
0.356 |
|
| 2017 |
Rivera B, Di Iorio M, Frankum J, Nadaf J, Fahiminiya S, Arcand SL, Burk DL, Grapton D, Tomiak E, Hastings V, Hamel N, Wagener R, Aleynikova O, Giroux S, Hamdan FF, ... ... Narod SA, et al. Functionally null RAD51D missense mutation associates strongly with ovarian carcinoma. Cancer Research. PMID 28646019 DOI: 10.1158/0008-5472.Can-17-0190 |
0.5 |
|
| 2017 |
Liede A, Mansfield CA, Metcalfe KA, Price MA, Snyder C, Lynch HT, Friedman S, Amelio J, Posner J, Narod SA, Lindeman GJ, Evans DG. Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Research and Treatment. PMID 28624978 DOI: 10.1007/S10549-017-4332-3 |
0.796 |
|
| 2017 |
Sopik V, Sun P, Narod SA. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients. Breast Cancer Research and Treatment. PMID 28601929 DOI: 10.1007/S10549-017-4333-2 |
0.548 |
|
| 2017 |
L Semple J, Metcalfe K, Shoukat F, Sun P, Narod S. Survival Differences in Women with and without Autologous Breast Reconstruction after Mastectomy for Breast Cancer. Plastic and Reconstructive Surgery. Global Open. 5: e1281. PMID 28507852 DOI: 10.1097/Gox.0000000000001281 |
0.758 |
|
| 2017 |
Durda K, Kąklewski K, Gupta S, Szydłowski M, Baszuk P, Jaworska-Bieniek K, Sukiennicki G, Kaczmarek K, Waloszczyk P, Narod S, Lubiński J, Jakubowska A. Serum folate concentration and the incidence of lung cancer. Plos One. 12: e0177441. PMID 28493936 DOI: 10.1371/Journal.Pone.0177441 |
0.422 |
|
| 2017 |
May T, Comeau R, Sun P, Kotsopoulos J, Narod SA, Rosen B, Ghatage P. A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 27: 668-674. PMID 28441250 DOI: 10.1097/Igc.0000000000000946 |
0.391 |
|
| 2017 |
Narod SA, Sopik V, Sun P. Which women decide to take tamoxifen? Breast Cancer Research and Treatment. PMID 28374324 DOI: 10.1007/S10549-017-4226-4 |
0.534 |
|
| 2017 |
McGee J, Giannakeas V, Karlan B, Lubinski J, Gronwald J, Rosen B, McLaughlin J, Risch H, Sun P, Foulkes WD, Neuhausen SL, Kotsopoulos J, Narod SA. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted? Gynecologic Oncology. PMID 28314588 DOI: 10.1016/J.Ygyno.2017.02.032 |
0.631 |
|
| 2017 |
Iqbal J, Amir E, Rochon PA, Giannakeas V, Sun P, Narod SA. Association of the Timing of Pregnancy With Survival in Women With Breast Cancer. Jama Oncology. PMID 28278319 DOI: 10.1001/Jamaoncol.2017.0248 |
0.556 |
|
| 2017 |
Jerzak K, Dudalski N, Pritchard K, Sun P, Narod SA. Does adjuvant radiation therapy benefit women with small mammography-detected breast cancers? Current Oncology (Toronto, Ont.). 24: 28-32. PMID 28270722 DOI: 10.3747/Co.24.3089 |
0.546 |
|
| 2017 |
Huzarski T, Górecka-Szyld B, Huzarska J, Psut-Muszyńska G, Wilk G, Sibilski R, Cybulski C, Kozak-Klonowska B, Siołek M, Kilar E, Czudowska D, Janiszewska H, Godlewski D, Mackiewicz A, Jarkiewicz-Tretyn J, ... ... Narod SA, et al. Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer. Hereditary Cancer in Clinical Practice. 15: 4. PMID 28265306 DOI: 10.1186/S13053-017-0064-Y |
0.544 |
|
| 2017 |
Goshen R, Mizrahi B, Akiva P, Kinar Y, Choman E, Shalev V, Sopik V, Kariv R, Narod SA. Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records. British Journal of Cancer. PMID 28253525 DOI: 10.1038/Bjc.2017.53 |
0.371 |
|
| 2017 |
Iqbal J, Ginsburg O, Fischer HD, Austin PC, Creatore MI, Narod SA, Rochon PA. A Population-Based Cross-Sectional Study Comparing Breast Cancer Stage at Diagnosis between Immigrant and Canadian-Born Women in Ontario. The Breast Journal. PMID 28252245 DOI: 10.1111/Tbj.12785 |
0.543 |
|
| 2017 |
Kim SJ, Rosen B, Fan I, Ivanova A, McLaughlin JR, Risch H, Narod SA, Kotsopoulos J. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer. British Journal of Cancer. PMID 28208158 DOI: 10.1038/Bjc.2017.35 |
0.459 |
|
| 2017 |
Lerner-Ellis J, Donenberg T, Ahmed H, George S, Wharfe G, Chin S, Lowe D, Royer R, Zhang S, Narod S, Hurley J, Akbari MR. A high frequency of PALB2 mutations in Jamaican patients with breast cancer. Breast Cancer Research and Treatment. PMID 28194609 DOI: 10.1007/S10549-017-4148-1 |
0.67 |
|
| 2017 |
Kinar Y, Akiva P, Choman E, Kariv R, Shalev V, Levin B, Narod SA, Goshen R. Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer. Plos One. 12: e0171759. PMID 28182647 DOI: 10.1371/Journal.Pone.0171759 |
0.376 |
|
| 2017 |
Akbari MR, Zhang S, Cragun D, Lee JH, Coppola D, McLaughlin J, Risch HA, Rosen B, Shaw P, Sellers TA, Schildkraut J, Narod SA, Pal T. Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens. Familial Cancer. PMID 28176205 DOI: 10.1007/S10689-017-9973-1 |
0.561 |
|
| 2017 |
Metcalfe KA, Semple J, Quan ML, Holloway C, Wright F, Narod S, Hofer S, Bagher S, Zhong T. Why Some Mastectomy Patients Opt to Undergo Delayed Breast Reconstruction: Results of a Long-Term Prospective Study. Plastic and Reconstructive Surgery. 139: 267-275. PMID 28121851 DOI: 10.1097/Prs.0000000000002943 |
0.701 |
|
| 2017 |
Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, Armel S, Karlan B, Foulkes WD, Neuhausen SL, Senter L, Tung N, Weitzel JN, Eisen A, Metcalfe K, ... ... Narod SA, et al. Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute. 109. PMID 27601060 DOI: 10.1093/Jnci/Djw177 |
0.801 |
|
| 2017 |
Metcalfe KA, Akbari MR, Narod S, Lerner-Ellis J. PALB2 mutations in high-risk women with breast or ovarian cancer. Journal of Clinical Oncology. 35: 1527-1527. DOI: 10.1200/Jco.2017.35.15_Suppl.1527 |
0.845 |
|
| 2017 |
Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, Dębniak T, Górski B, Sopik V, Akbari MR, Sun P, Gronwald J, Narod SA, et al. Meeting abstracts from the Annual Conference on Hereditary Cancers 2016 Hereditary Cancer in Clinical Practice. 15: 1-6. DOI: 10.1186/S13053-017-0081-X |
0.501 |
|
| 2017 |
Moran OM, Nikitina D, Gunasekara A, Yaffe MJ, Metcalfe KA, Narod SA, Kotsopoulos J. Abstract B12: The effect of physical activity and body size on mammographic density in high-risk, BRCA mutation-negative women Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-B12 |
0.765 |
|
| 2017 |
Salmena L, Oden L, Kim S, Akbari M, Sun P, Narod S, Kotsopoulos J. Abstract A23: Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-A23 |
0.67 |
|
| 2017 |
Kotsopoulos J, Oden L, Akbari M, Singer C, Sun P, Salmena L, Narod S. Abstract P5-09-01: Plasma osteoprotegerin and the risk of breast cancer inBRCA1andBRCA2mutation carriers Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-09-01 |
0.545 |
|
| 2017 |
Rivera B, Iorio MRD, Frankum J, Nadaf J, Fahiminiya S, Arcand SL, Burk D, Grapton D, Tomiak E, Hastings V, Hamel N, Wagener R, Aleynikova O, Giroux S, Hamdan FF, ... ... Narod S, et al. Abstract 2479: A functionally nullRAD51Dmissense mutation is strongly associated with ovarian carcinoma Cancer Research. 77: 2479-2479. DOI: 10.1158/1538-7445.Am2017-2479 |
0.345 |
|
| 2016 |
Nguyen J, Le QH, Duong BH, Sun P, Pham HT, Ta VT, Kotsopoulos J, Narod SA, Ginsburg O. A Matched Case-Control Study of Risk Factors for Breast Cancer Risk in Vietnam. International Journal of Breast Cancer. 2016: 7164623. PMID 28070424 DOI: 10.1155/2016/7164623 |
0.591 |
|
| 2016 |
Narod S, Sopik V. Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted? Gynecologic Oncology. PMID 28017307 DOI: 10.1016/J.Ygyno.2016.11.046 |
0.416 |
|
| 2016 |
Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, ... ... Narod SA, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology. PMID 27941069 DOI: 10.1093/Aje/Kww161 |
0.461 |
|
| 2016 |
Odén L, Akbari M, Zaman T, Singer CF, Sun P, Narod SA, Salmena L, Kotsopoulos J. Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Oncotarget. PMID 27893411 DOI: 10.18632/Oncotarget.13417 |
0.654 |
|
| 2016 |
Narod SA. Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. Jama Oncology. PMID 27832244 DOI: 10.1001/Jamaoncol.2016.3952 |
0.474 |
|
| 2016 |
Moran O, Nikitina D, Royer R, Poll A, Metcalfe K, Narod SA, Akbari MR, Kotsopoulos J. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Breast Cancer Research and Treatment. PMID 27798748 DOI: 10.1007/S10549-016-4038-Y |
0.812 |
|
| 2016 |
Iqbal J, Ginsburg O, Giannakeas V, Rochon PA, Semple JL, Narod SA. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer. Breast Cancer Research and Treatment. PMID 27796715 DOI: 10.1007/S10549-016-4015-5 |
0.558 |
|
| 2016 |
Kotsopoulos J, Singer C, Narod SA. Can we prevent BRCA1-associated breast cancer by RANKL inhibition? Breast Cancer Research and Treatment. PMID 27783278 DOI: 10.1007/S10549-016-4029-Z |
0.665 |
|
| 2016 |
Kotsopoulos J, Sopik V, Rosen B, Fan I, McLaughlin JR, Risch H, Sun P, Narod SA, Akbari MR. Frequency of germline PALB2 mutations among women with epithelial ovarian cancer. Familial Cancer. PMID 27631815 DOI: 10.1007/S10689-016-9919-Z |
0.535 |
|
| 2016 |
Eng LG, Dawood S, Sopik V, Haaland B, Tan PS, Bhoo-Pathy N, Warner E, Iqbal J, Narod SA, Dent R. Ten-year survival in women with primary stage IV breast cancer. Breast Cancer Research and Treatment. PMID 27628191 DOI: 10.1007/S10549-016-3974-X |
0.565 |
|
| 2016 |
Menkiszak J, Sopik V, Chudecka-Głaz A, Domagała W, Urasińska E, Symonowicz H, Majdanik E, Waloszczyk P, Sycz K, Świniarska M, Huzarski T, Cybulski C, Debniak T, Oszurek O, Lubinski J, ... Narod SA, et al. The Impact of an Expanded Genetic Testing Program and Selective Oophorectomy on the Incidence of Ovarian Cancer in West Pomerania. Clinical Genetics. PMID 27623744 DOI: 10.1111/Cge.12865 |
0.554 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Narod SA, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.476 |
|
| 2016 |
Metcalfe KA, Dennis CL, Poll A, Armel S, Demsky R, Carlsson L, Nanda S, Kiss A, Narod SA. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27584910 DOI: 10.1038/Gim.2016.108 |
0.821 |
|
| 2016 |
Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA. Low-grade serous ovarian cancer: A review. Gynecologic Oncology. PMID 27581327 DOI: 10.1016/j.ygyno.2016.08.320 |
0.417 |
|
| 2016 |
Jonasson JG, Stefansson OA, Johannsson OT, Sigurdsson H, Agnarsson BA, Olafsdottir GH, Alexiusdottir KK, Stefansdottir H, Munoz Mitev R, Olafsdottir K, Olafsdottir K, Arason A, Stefansdottir V, Olafsdottir EJ, Barkardottir RB, ... ... Narod SA, et al. Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers. British Journal of Cancer. PMID 27537391 DOI: 10.1038/Bjc.2016.249 |
0.605 |
|
| 2016 |
Chehade R, Pettapiece-Phillips R, Salmena L, Kotlyar M, Jurisica I, Narod SA, Akbari MR, Kotsopoulos J. Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific. Breast Cancer Research : Bcr. 18: 87. PMID 27534398 DOI: 10.1186/S13058-016-0739-8 |
0.572 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Narod SA, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.414 |
|
| 2016 |
Wallis CJ, Mahar AL, Satkunasivam R, Herschorn S, Kodama RT, Lee Y, Kulkarni GS, Narod SA, Nam RK. Cardiovascular and Skeletal-Related Events Following Localised Prostate Cancer Treatment: Role of Surgery, Radiotherapy and Androgen-Deprivation. Urology. PMID 27502032 DOI: 10.1016/J.Urology.2016.08.002 |
0.325 |
|
| 2016 |
Donenberg T, Ahmed H, Royer R, Zhang S, Narod SA, George S, Akbari MR, Ali J, Hurley J. A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago. Breast Cancer Research and Treatment. PMID 27469594 DOI: 10.1007/S10549-016-3870-4 |
0.635 |
|
| 2016 |
Kim SJ, Zuchniak A, Sohn KJ, Lubinski J, Demsky R, Eisen A, Akbari MR, Kim YI, Narod SA, Kotsopoulos J. Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study. The American Journal of Clinical Nutrition. PMID 27465373 DOI: 10.3945/Ajcn.116.133470 |
0.481 |
|
| 2016 |
Narod SA. Response to 'Comments on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study''. British Journal of Cancer. PMID 27459693 DOI: 10.1038/Bjc.2016.225 |
0.483 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Narod SA, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.47 |
|
| 2016 |
Giannakeas V, Sopik V, Narod SA. A model for ovarian cancer progression based on inherent resistance. Gynecologic Oncology. PMID 27388695 DOI: 10.1016/J.Ygyno.2016.06.014 |
0.461 |
|
| 2016 |
Sopik V, Iqbal J, Sun P, Narod SA. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer. Breast Cancer Research and Treatment. PMID 27383477 DOI: 10.1007/S10549-016-3894-9 |
0.6 |
|
| 2016 |
Narod SA. Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer. The New England Journal of Medicine. 374: 2602. PMID 27355550 DOI: 10.1056/NEJMc1603849#SA1 |
0.367 |
|
| 2016 |
Wallis CJ, Mahar AL, Cheung P, Herschorn S, Satkunasivam R, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older Men. Urology. PMID 27289026 DOI: 10.1016/J.Urology.2016.05.054 |
0.322 |
|
| 2016 |
Sopik V, Narod SA. Common genetic susceptibility to DCIS and invasive ductal carcinoma. Breast Cancer Research : Bcr. 18: 60. PMID 27286830 DOI: 10.1186/S13058-016-0719-Z |
0.535 |
|
| 2016 |
Kwong A, Shin VY, Cheuk IW, Chen J, Au CH, Ho DN, Chan TL, Ma ES, Akbari MR, Narod SA. Germline RECQL mutations in high risk Chinese breast cancer patients. Breast Cancer Research and Treatment. PMID 27125668 DOI: 10.1007/S10549-016-3784-1 |
0.609 |
|
| 2016 |
Narod SA. Talc and ovarian cancer. Gynecologic Oncology. 141: 410-2. PMID 27095190 DOI: 10.1016/J.Ygyno.2016.04.011 |
0.491 |
|
| 2016 |
Liede A, Jerzak KJ, Hernandez RK, Wade SW, Sun P, Narod SA. The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Research and Treatment. 156: 587-95. PMID 27083181 DOI: 10.1007/S10549-016-3782-3 |
0.492 |
|
| 2016 |
Cybulski C, Carrot-Zhang J, Kluźniak W, Rivera B, Kashyap A, Wokołorczyk D, Giroux S, Nadaf J, Hamel N, Zhang S, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, ... ... Narod SA, et al. Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility. Nature Genetics. 48: 473. PMID 27023777 DOI: 10.1038/Ng0329-473C |
0.386 |
|
| 2016 |
Iqbal J, Nussenzweig A, Lubinski J, Byrski T, Eisen A, Bordeleau L, Tung NM, Manoukian S, Phelan CM, Sun P, Narod SA. The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study. British Journal of Cancer. PMID 26986251 DOI: 10.1038/bjc.2016.58 |
0.558 |
|
| 2016 |
Huzarski T, Byrski T, Gronwald J, Cybulski C, Oszurek O, Szwiec M, Gugała K, Stawicka M, Morawiec Z, Mierzwa T, Falco M, Janiszewska H, Kilar E, Marczyk E, Kozak-Klonowska B, ... ... Narod SA, et al. The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients. Breast Cancer Research and Treatment. PMID 26983446 DOI: 10.1007/S10549-016-3749-4 |
0.624 |
|
| 2016 |
Narod SA, Sopik V, Sun P. DCIS and invasive interval breast cancer. The Lancet. Oncology. 17: e87-8. PMID 26972859 DOI: 10.1016/S1470-2045(16)00023-1 |
0.583 |
|
| 2016 |
Wallis CJ, Mahar AL, Choo R, Herschorn S, Kodama RT, Shah PS, Danjoux C, Narod SA, Nam RK. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. Bmj (Clinical Research Ed.). 352: i851. PMID 26936410 DOI: 10.1136/Bmj.I851 |
0.4 |
|
| 2016 |
Narod SA, Sopik V, Giannakeas V. Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial. Gynecologic Oncology. 141: 191-4. PMID 26915499 DOI: 10.1016/J.Ygyno.2016.02.020 |
0.401 |
|
| 2016 |
Narod SA. Differing Perspectives on Breast Cancer Chemoprevention-Reply. Jama Oncology. 2: 277. PMID 26869002 DOI: 10.1001/jamaoncol.2015.4395 |
0.52 |
|
| 2016 |
Wojcik P, Jasiowka M, Strycharz E, Sobol M, Hodorowicz-Zaniewska D, Skotnicki P, Byrski T, Blecharz P, Marczyk E, Cedrych I, Jakubowicz J, Lubiński J, Sopik V, Narod S, Pierzchalski P. Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland. Hereditary Cancer in Clinical Practice. 14: 5. PMID 26843898 DOI: 10.1186/S13053-016-0046-5 |
0.617 |
|
| 2016 |
Narod S. Can advanced-stage ovarian cancer be cured? Nature Reviews Clinical Oncology. 13: 255-261. PMID 26787282 DOI: 10.1038/Nrclinonc.2015.224 |
0.464 |
|
| 2016 |
Kotsopoulos J, Huzarski T, Gronwald J, Moller P, Lynch HT, Neuhausen SL, Senter L, Demsky R, Foulkes WD, Eng C, Karlan B, Tung N, Singer CF, Sun P, Lubinski J, ... Narod SA, et al. Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study. Breast Cancer Research and Treatment. PMID 26780555 DOI: 10.1007/S10549-016-3685-3 |
0.621 |
|
| 2016 |
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... ... Narod S, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315 |
0.609 |
|
| 2016 |
Narod S. Breast cancer: The importance of overdiagnosis in breast-cancer screening. Nature Reviews Clinical Oncology. 13: 5-6. PMID 26573419 DOI: 10.1038/Nrclinonc.2015.203 |
0.565 |
|
| 2016 |
Pettapiece-Phillips R, Kotlyar M, Chehade R, Salmena L, Narod SA, Akbari M, Jurisica I, Kotsopoulos J. Uninterrupted Sedentary Behavior Downregulates BRCA1 Gene Expression. Cancer Prevention Research (Philadelphia, Pa.). 9: 83-8. PMID 26526989 DOI: 10.1158/1940-6207.Capr-15-0291 |
0.442 |
|
| 2016 |
Narod S. Genetic Testing for BRCA Mutations Today and Tomorrow-About the ABOUT Study. Jama Oncology. 1: 1225-6. PMID 26426337 DOI: 10.1001/Jamaoncol.2015.3269 |
0.411 |
|
| 2016 |
Metcalfe KA, Narod S, Eisen A, Lerner-Ellis J. Treatment decision making and psychosocial outcomes associated with rapid genetic testing for BRCA1 and BRCA2 in women newly diagnosed with breast cancer. Journal of Clinical Oncology. 34: 1586-1586. DOI: 10.1200/Jco.2016.34.15_Suppl.1586 |
0.758 |
|
| 2016 |
Lin H, Xiong Y, Tyrer J, Marchion DC, Monteiro AN, Berchuck A, Schildkraut JM, Goode EL, Ramus SJ, Gayther SA, Pharoah PD, Narod SA, Sellers TA, Phelan CM. Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B27 |
0.417 |
|
| 2016 |
Kotsopoulos J, Fan I, McLaughlin J, Rosen B, May T, Risch H, Sun P, Narod S. Abstract B21:BRCAmutation status is not associated with better long-term survival from epithelial ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B21 |
0.528 |
|
| 2016 |
George SH, Donenberg T, Akbari M, Alexis C, Wharfe G, Dyer H, Yin S, Turnquest T, Ali J, DeGennaro V, Narod SA, Hurley J. Abstract B50: Breast cancer in the Caribbean – A six-country cohort Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B50 |
0.634 |
|
| 2016 |
Wallis C, Lo K, Lee Y, Krakowsky Y, Garbens A, Satkunasivam R, Herschorn S, Kodama R, Cheung P, Narod S, Nam R. PD50-03 CARDIOVASCULAR EVENTS AND PROSTATE CANCER DIAGNOSES IN MEN TREATED WITH TESTOSTERONE REPLACEMENT THERAPY Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2793 |
0.307 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Narod SA, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.361 |
|
| 2015 |
Sopik V, Nofech-Mozes S, Sun P, Narod SA. The relationship between local recurrence and death in early-stage breast cancer. Breast Cancer Research and Treatment. PMID 26712515 DOI: 10.1007/S10549-015-3666-Y |
0.602 |
|
| 2015 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Narod SA, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B |
0.333 |
|
| 2015 |
Gronwald J, Glass K, Rosen B, Karlan B, Tung N, Neuhausen SL, Moller P, Ainsworth P, Sun P, Narod SA, Lubinski J, Kotsopoulos J. Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Fertility and Sterility. PMID 26698676 DOI: 10.1016/J.Fertnstert.2015.11.034 |
0.555 |
|
| 2015 |
Nikitina D, Chen Z, Vallis K, Poll A, Ainsworth P, Narod SA, Kotsopoulos J. Relationship between Caffeine and Levels of DNA Repair and Oxidative Stress in Women with and without a BRCA1 Mutation. Journal of Nutrigenetics and Nutrigenomics. 8: 174-184. PMID 26670362 DOI: 10.1159/000439110 |
0.433 |
|
| 2015 |
Wallis CJ, Mahar A, Cheung P, Herschorn S, Klotz LH, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men. European Urology. PMID 26572707 DOI: 10.1016/J.Eururo.2015.10.043 |
0.317 |
|
| 2015 |
Kotsopoulos J, Rosen B, Fan I, Moody J, McLaughlin JR, Risch H, May T, Sun P, Narod SA. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status. Gynecologic Oncology. PMID 26556769 DOI: 10.1016/J.Ygyno.2015.11.009 |
0.418 |
|
| 2015 |
Lerner-Ellis J, Khalouei S, Sopik V, Narod SA. Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer. Expert Review of Anticancer Therapy. 15: 1315-26. PMID 26523341 DOI: 10.1586/14737140.2015.1090879 |
0.645 |
|
| 2015 |
Nam RK, Amemiya Y, Benatar T, Wallis CJ, Stojcic-Bendavid J, Bacopulos S, Sherman C, Sugar L, Naeim M, Yang W, Zhang A, Klotz LH, Narod SA, Seth A. Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study. Journal of Cancer. 6: 1160-71. PMID 26516365 DOI: 10.7150/Jca.13397 |
0.316 |
|
| 2015 |
Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, ... ... Narod SA, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nature Reviews. Cancer. 15: 668-79. PMID 26493647 DOI: 10.1038/Nrc4019 |
0.489 |
|
| 2015 |
Semple J, Metcalfe KA, Lubinski J, Huzarski T, Gronwald J, Armel S, Lynch HT, Karlan B, Foulkes W, Singer CF, Neuhausen SL, Eng C, Iqbal J, Narod SA. Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? Breast Cancer Research and Treatment. 154: 163-9. PMID 26467043 DOI: 10.1007/S10549-015-3596-8 |
0.832 |
|
| 2015 |
Giannakeas V, Sopik V, Shestopaloff K, Iqbal J, Rosen B, Akbari M, Narod SA. A model for estimating ovarian cancer risk: Application for preventive oophorectomy. Gynecologic Oncology. 139: 242-7. PMID 26341709 DOI: 10.1016/J.Ygyno.2015.08.020 |
0.584 |
|
| 2015 |
Narod SA, Dent RA, Foulkes WD. CCR 20th Anniversary Commentary: Triple-Negative Breast Cancer in 2015—Still in the Ballpark. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3813-4. PMID 26330504 DOI: 10.1158/1078-0432.CCR-14-3122 |
0.516 |
|
| 2015 |
Metcalfe KA, Eisen A, Lerner-Ellis J, Narod SA. Is it time to offer BRCA1 and BRCA2 testing to all Jewish women? Current Oncology (Toronto, Ont.). 22: e233-6. PMID 26300672 DOI: 10.3747/Co.22.2527 |
0.638 |
|
| 2015 |
Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. Jama Oncology. PMID 26291673 DOI: 10.1001/Jamaoncol.2015.2510 |
0.59 |
|
| 2015 |
Pal T, Bonner D, Cragun D, Monteiro AN, Phelan C, Servais L, Kim J, Narod SA, Akbari MR, Vadaparampil ST. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer. PMID 26287763 DOI: 10.1002/Cncr.29645 |
0.632 |
|
| 2015 |
Kotsopoulos J, Lubinski J, Neuhausen SL, Gronwald J, Lynch HT, Huzarski T, Demsky R, Foulkes WD, Senter L, Friedman S, Ainsworth P, Sun P, Narod SA. Weight gain after oophorectomy among women with a BRCA1 or BRCA2 mutation. Women's Health (London, England). 11: 453-9. PMID 26258912 DOI: 10.2217/WHE.15.4 |
0.345 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Narod SA, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.313 |
|
| 2015 |
Iqbal J, Ferdousy T, Dipi R, Salim R, Wu W, Narod SA, Kotsopoulos J, Mostafa MG, Ginsburg O. Risk Factors for Premenopausal Breast Cancer in Bangladesh. International Journal of Breast Cancer. 2015: 612042. PMID 26229688 DOI: 10.1155/2015/612042 |
0.624 |
|
| 2015 |
Finch A, Wang M, Fine A, Atri L, Khalouei S, Pupavac M, Rosen B, Eisen A, Elser C, Charames G, Metcalfe K, Chang MC, Narod SA, Lerner-Ellis J. Genetic testing for BRCA1 and BRCA2 in the Province of Ontario. Clinical Genetics. PMID 26219728 DOI: 10.1111/Cge.12647 |
0.763 |
|
| 2015 |
Metcalfe KA, Cil TD, Semple JL, Li LD, Bagher S, Zhong T, Virani S, Narod S, Pal T. Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference? Annals of Surgical Oncology. PMID 26208581 DOI: 10.1245/S10434-015-4761-3 |
0.766 |
|
| 2015 |
Kwong A, Shin VY, Ho JC, Kang E, Nakamura S, Teo SH, Lee AS, Sng JH, Ginsburg OM, Kurian AW, Weitzel JN, Siu MT, Law FB, Chan TL, Narod SA, et al. Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. Journal of Medical Genetics. PMID 26187060 DOI: 10.1136/Jmedgenet-2015-103132 |
0.61 |
|
| 2015 |
Klein J, Kong I, Paszat L, Nofech-Mozes S, Hanna W, Thiruchelvam D, Narod SA, Saskin R, Done SJ, Miller N, Youngson B, Tuck A, Sengupta S, Elavathil L, Jani PA, et al. Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis. Springerplus. 4: 335. PMID 26185737 DOI: 10.1186/S40064-015-1032-5 |
0.339 |
|
| 2015 |
Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Jama Oncology. 1: 306-13. PMID 26181175 DOI: 10.1001/Jamaoncol.2015.0658 |
0.836 |
|
| 2015 |
Narod SA. Have we given up on a cure for ovarian cancer Current Oncology. 22: 139-141. PMID 26089723 DOI: 10.3747/Co.22.2517 |
0.601 |
|
| 2015 |
Narod SA. Counterpoint re: "Mammography screening-sticking to the science". Current Oncology. 22: 177-177. PMID 26089714 DOI: 10.3747/Co.22.2457 |
0.507 |
|
| 2015 |
Sopik V, Rosen B, Giannakeas V, Narod SA. Why have ovarian cancer mortality rates declined? Part III. Prospects for the future. Gynecologic Oncology. 138: 757-61. PMID 26086565 DOI: 10.1016/J.Ygyno.2015.06.019 |
0.508 |
|
| 2015 |
Sopik V, Iqbal J, Rosen B, Narod SA. Why have ovarian cancer mortality rates declined? Part II. Case-fatality. Gynecologic Oncology. 138: 750-6. PMID 26080288 DOI: 10.1016/J.Ygyno.2015.06.016 |
0.43 |
|
| 2015 |
Sopik V, Iqbal J, Rosen B, Narod SA. Why have ovarian cancer mortality rates declined? Part I. Incidence. Gynecologic Oncology. 138: 741-9. PMID 26080287 DOI: 10.1016/J.Ygyno.2015.06.017 |
0.448 |
|
| 2015 |
Cybulski C, Klu?niak W, Huzarski T, Woko?orczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, D?bniak T, Górski B, Sopik V, Akbari MR, Sun P, Gronwald J, Narod SA, et al. Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. The Lancet. Oncology. 16: 638-44. PMID 25959805 DOI: 10.1016/S1470-2045(15)70142-7 |
0.662 |
|
| 2015 |
Holter S, Borgida A, Dodd A, Grant R, Semotiuk K, Hedley D, Dhani N, Narod S, Akbari M, Moore M, Gallinger S. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 25940717 DOI: 10.1200/Jco.2014.59.7401 |
0.385 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Narod SA, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.473 |
|
| 2015 |
Cybulski C, Lubinski J, Huzarski T, Lynch HT, Randall SA, Neuhausen SL, Senter L, Friedman S, Ainsworth P, Singer C, Foulkes WD, Narod SA, Sun P, Kotsopoulos J. Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 151: 435-41. PMID 25935583 DOI: 10.1007/s10549-015-3393-4 |
0.501 |
|
| 2015 |
Arcand SL, Akbari MR, Mes-Masson AM, Provencher D, Foulkes WD, Narod SA, Tonin PN. Germline TP53 mutational spectrum in French Canadians with breast cancer. Bmc Medical Genetics. 16: 24. PMID 25925845 DOI: 10.1186/S12881-015-0169-Y |
0.613 |
|
| 2015 |
Narod SA, Kharazmi E, Fallah M, Sundquist K, Hemminki K. The risk of contralateral breast cancer in daughters of women with and without breast cancer. Clinical Genetics. PMID 25920602 DOI: 10.1111/Cge.12604 |
0.645 |
|
| 2015 |
Trottier M, Lunn J, Butler R, Curling D, Turnquest T, Francis W, Halliday D, Royer R, Zhang S, Li S, Thompson I, Donenberg T, Hurley J, Akbari MR, Narod SA. Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas. Clinical Genetics. PMID 25920394 DOI: 10.1111/Cge.12602 |
0.633 |
|
| 2015 |
Cybulski C, Carrot-Zhang J, Klu?niak W, Rivera B, Kashyap A, Woko?orczyk D, Giroux S, Nadaf J, Hamel N, Zhang S, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, ... ... Narod SA, et al. Germline RECQL mutations are associated with breast cancer susceptibility. Nature Genetics. 47: 643-6. PMID 25915596 DOI: 10.1038/Ng.3284 |
0.602 |
|
| 2015 |
Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, Garcia JD, Vadaparampil ST, Pal T. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Research and Treatment. 151: 169-76. PMID 25868867 DOI: 10.1007/S10549-015-3374-7 |
0.519 |
|
| 2015 |
Narod SA. Breast cancer prevention in the era of precision medicine. Journal of the National Cancer Institute. 107. PMID 25855708 DOI: 10.1093/Jnci/Djv078 |
0.591 |
|
| 2015 |
Narod SA, Giannakeas V, Miller AB. Re: Pan-Canadian study of mammography screening and mortality from breast cancer. Journal of the National Cancer Institute. 107. PMID 25855706 DOI: 10.1093/jnci/djv094 |
0.437 |
|
| 2015 |
Segev Y, Rosen B, Lubinski J, Gronwald J, Lynch HT, Moller P, Kim-Sing C, Ghadirian P, Karlan B, Eng C, Gilchrist D, Neuhausen SL, Eisen A, Friedman E, Euhus D, ... ... Narod SA, et al. Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study. Familial Cancer. PMID 25838159 DOI: 10.1007/S10689-015-9798-8 |
0.526 |
|
| 2015 |
Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, Librado P, Sánchez-Gracia A, Rozas J, Bonifaci N, McGuffog L, Pankratz VS, Islam A, Mateo F, Berenguer A, ... ... Narod SA, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. Plos One. 10: e0120020. PMID 25830658 DOI: 10.1371/Journal.Pone.0120020 |
0.588 |
|
| 2015 |
Liede A, Sun P, Narod S. Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers. Jama Surgery. 150: 490-1. PMID 25807333 DOI: 10.1001/Jamasurg.2015.0193 |
0.634 |
|
| 2015 |
Snyder C, Metcalfe K, Sopik V, Royer R, Zhang S, Narod SA, Akbari MR, Lynch HT. Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry. Breast Cancer Research and Treatment. 150: 637-41. PMID 25794774 DOI: 10.1007/S10549-015-3347-X |
0.797 |
|
| 2015 |
Lipscombe LL, Fischer HD, Austin PC, Fu L, Jaakkimainen RL, Ginsburg O, Rochon PA, Narod S, Paszat L. The association between diabetes and breast cancer stage at diagnosis: a population-based study. Breast Cancer Research and Treatment. 150: 613-20. PMID 25779100 DOI: 10.1007/S10549-015-3323-5 |
0.511 |
|
| 2015 |
Wallis CJ, Herschorn S, Saskin R, Su J, Klotz LH, Chang M, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Complications after radical prostatectomy or radiotherapy for prostate cancer: results of a population-based, propensity score-matched analysis. Urology. 85: 621-7. PMID 25733275 DOI: 10.1016/J.Urology.2014.11.037 |
0.311 |
|
| 2015 |
Villarreal-Garza C, Weitzel JN, Llacuachaqui M, Sifuentes E, Magallanes-Hoyos MC, Gallardo L, Alvarez-Gómez RM, Herzog J, Castillo D, Royer R, Akbari M, Lara-Medina F, Herrera LA, Mohar A, Narod SA. The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer. Breast Cancer Research and Treatment. 150: 389-94. PMID 25716084 DOI: 10.1007/S10549-015-3312-8 |
0.613 |
|
| 2015 |
Wallis CJ, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer. British Journal of Cancer. 112: 977-82. PMID 25688739 DOI: 10.1038/Bjc.2015.54 |
0.326 |
|
| 2015 |
Wong-Brown MW, Meldrum CJ, Carpenter JE, Clarke CL, Narod SA, Jakubowska A, Rudnicka H, Lubinski J, Scott RJ. Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Research and Treatment. 150: 71-80. PMID 25682074 DOI: 10.1007/S10549-015-3293-7 |
0.623 |
|
| 2015 |
Nikitina D, Llacuachaqui M, Sepkovic D, Bradlow HL, Narod SA, Kotsopoulos J. The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers. Familial Cancer. 14: 281-6. PMID 25613194 DOI: 10.1007/S10689-015-9783-2 |
0.514 |
|
| 2015 |
Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. Jama. 313: 165-73. PMID 25585328 DOI: 10.1001/Jama.2014.17322 |
0.574 |
|
| 2015 |
Sio?ek M, Cybulski C, G?sior-Perczak D, Kowalik A, Kozak-Klonowska B, Kowalska A, Ch?opek M, Klu?niak W, Woko?orczyk D, Pa?yga I, Walczyk A, Lizis-Kolus K, Sun P, Lubi?ski J, Narod SA, et al. CHEK2 mutations and the risk of papillary thyroid cancer. International Journal of Cancer. Journal International Du Cancer. 137: 548-52. PMID 25583358 DOI: 10.1002/Ijc.29426 |
0.628 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Narod SA, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.406 |
|
| 2015 |
Pettapiece-Phillips R, Narod SA, Kotsopoulos J. The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers. Cancer Causes & Control : Ccc. 26: 333-44. PMID 25579073 DOI: 10.1007/S10552-014-0521-0 |
0.607 |
|
| 2015 |
Metcalfe KA, Zhong T, Narod SA, Quan ML, Holloway C, Hofer S, Bagher S, Semple J. A prospective study of mastectomy patients with and without delayed breast reconstruction: long-term psychosocial functioning in the breast cancer survivorship period. Journal of Surgical Oncology. 111: 258-64. PMID 25557452 DOI: 10.1002/Jso.23829 |
0.732 |
|
| 2015 |
Jerzak KJ, Cockburn J, Pond GR, Pritchard KI, Narod SA, Dhesy-Thind SK, Bane A. Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications. Breast Cancer Research and Treatment. 149: 293-301. PMID 25542270 DOI: 10.1007/S10549-014-3235-9 |
0.415 |
|
| 2015 |
Kotsopoulos J, Shafrir AL, Rice M, Hankinson SE, Eliassen AH, Tworoger SS, Narod SA. The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women. Hormones & Cancer. 6: 54-63. PMID 25523946 DOI: 10.1007/s12672-014-0209-7 |
0.303 |
|
| 2015 |
Sopik V, Akbari MR, Narod SA. Genetic testing for RAD51C mutations: in the clinic and community Clinical Genetics. 88: 303-312. PMID 25470109 DOI: 10.1111/Cge.12548 |
0.62 |
|
| 2015 |
Torres-Mejía G, Royer R, Llacuachaqui M, Akbari MR, Giuliano AR, Martínez-Matsushita L, Angeles-Llerenas A, Ortega-Olvera C, Ziv E, Lazcano-Ponce E, Phelan CM, Narod SA. Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 498-505. PMID 25371446 DOI: 10.1158/1055-9965.Epi-13-0980 |
0.665 |
|
| 2015 |
Schütz E, Akbari MR, Beck J, Urnovitz H, Zhang WW, Bornemann-Kolatzki K, Mitchell WM, Nam RK, Narod SA. Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer. Clinical Chemistry. 61: 239-48. PMID 25348670 DOI: 10.1373/Clinchem.2014.226571 |
0.319 |
|
| 2015 |
Cybulski C, Lubiński J, Wokołorczyk D, Kuźniak W, Kashyap A, Sopik V, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, Górski B, Dębniak T, Narod SA, Akbari MR. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland. Clinical Genetics. 88: 366-70. PMID 25330149 DOI: 10.1111/Cge.12524 |
0.654 |
|
| 2015 |
Sopik V, Phelan C, Cybulski C, Narod SA. BRCA1 and BRCA2 mutations and the risk for colorectal cancer Clinical Genetics. 87: 411-418. PMID 25195694 DOI: 10.1111/Cge.12497 |
0.622 |
|
| 2015 |
Antczak A, Wokołorczyk D, Kluźniak W, Kashyap A, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dębniak T, Masojć B, Górski B, Gromowski T, Gołęb A, Sikorski A, Słojewski M, ... ... Narod SA, et al. The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men European Journal of Cancer Prevention. 24: 122-127. PMID 25187206 DOI: 10.1097/Cej.0000000000000079 |
0.387 |
|
| 2015 |
Trottier M, Lunn J, Butler R, Curling D, Turnquest T, Royer R, Akbari MR, Donenberg T, Hurley J, Narod SA. Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas. Clinical Genetics. 88: 182-6. PMID 25060751 DOI: 10.1111/Cge.12468 |
0.497 |
|
| 2015 |
Szwiec M, Jakubowska A, Górski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, Dębniak T, Byrski T, Kluźniak W, Wokołorczyk D, Birkenfeld B, Akbari MR, Narod SA, Lubiński J, Cybulski C. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. Clinical Genetics. 87: 288-292. PMID 24528374 DOI: 10.1111/Cge.12360 |
0.548 |
|
| 2015 |
Snyder CL, Metcalfe KA, Sopik V, Royer R, Becirovic D, Narod S, Wang SM, Akbari MR, Lynch HT. Prevalence of PALB2 mutations in the Creighton University breast cancer family registry. Journal of Clinical Oncology. 33: e12519-e12519. DOI: 10.1200/jco.2015.33.15_suppl.e12519 |
0.532 |
|
| 2015 |
Metcalfe KA, Poll A, Llacuachaqui M, Virani S, Nanda S, Sun P, Narod S. Patient-reported outcomes associated with population-based Jewish genetic testing for BRCA1 and BRCA2. Journal of Clinical Oncology. 33: 1531-1531. DOI: 10.1200/Jco.2015.33.15_Suppl.1531 |
0.795 |
|
| 2015 |
Byrski T, Huzarski T, Dent R, Marczyk E, Jasiowka M, Gronwald J, Jakubowicz J, Cybulski C, Wisniowski R, Godlewski D, Lubinski J, Narod SA. Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Hereditary Cancer in Clinical Practice. 13: 1-1. DOI: 10.1186/1897-4287-13-S2-A8 |
0.564 |
|
| 2015 |
George SH, Donenberg T, Akbari M, Alexis C, Wharfe G, Yin S, Dyer H, Turnquest T, DeGennaro V, Narod S, Hurley J. Abstract P3-08-06: Demographics of breast cancer in a cohort of Afro-Caribbean women Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-08-06 |
0.654 |
|
| 2015 |
Kim SJ, Zuchniak A, Kim Y, Lamers Y, Kotsopoulos J, Narod S. Abstract LB-185: The effects of plasma folate and other B vitamins on breast cancer risk in BRCA1 and BRCA2 mutation carriers Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-185 |
0.62 |
|
| 2015 |
Wojdacz TK, Gupta S, Jaworska-Bieniek K, Harari F, Narod S, Broberg K, Hansen LL, Lubinski J, Jakubowska A. Abstract LB-159: Methylation of BRCA1 gene in blood is not inherited via maternal germ line and may predispose to triple-negative or medullary breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-159 |
0.619 |
|
| 2015 |
Chehade R, Pettapiece-Phillips R, Akbari M, Salmena L, Narod S, Kotsopoulos J. Abstract 2750: Modulation of BRCA1 expression as a preventative method for BRCA1-associated breast cancer Cancer Research. 75: 2750-2750. DOI: 10.1158/1538-7445.Am2015-2750 |
0.594 |
|
| 2015 |
Wallis C, Mahar A, Cheung P, Herschorn S, Klotz L, Al-Matar A, Kulkarni G, Lee Y, Kodama R, Narod S, Nam R. MP14-08 THE INCIDENCE OF TREATMENT-RELATED COMPLICATIONS WITH CONTEMPORARY TREATMENT FOR CLINICALLY-LOCALIZED PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.870 |
0.322 |
|
| 2015 |
Narod SA, Iqbal J, Miller AB. Why have breast cancer mortality rates declined? Journal of Cancer Policy. 5: 8-17. DOI: 10.1016/J.Jcpo.2015.03.002 |
0.589 |
|
| 2014 |
Sopik V, Narod SA. Overdiagnosis in breast cancer chemoprevention trials Current Oncology. 22: 6-10. PMID 25684995 DOI: 10.3747/Co.22.2191 |
0.592 |
|
| 2014 |
Kotsopoulos J, Lubinski J, Gronwald J, Cybulski C, Demsky R, Neuhausen SL, Kim-Sing C, Tung N, Friedman S, Senter L, Weitzel J, Karlan B, Moller P, Sun P, Narod SA, et al. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. Journal International Du Cancer. PMID 25482078 DOI: 10.1002/ijc.29386 |
0.462 |
|
| 2014 |
Gupta S, Jaworska-Bieniek K, Narod SA, Lubinski J, Wojdacz TK, Jakubowska A. Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer. Breast Cancer Research and Treatment. 148: 615-22. PMID 25376744 DOI: 10.1007/S10549-014-3179-0 |
0.58 |
|
| 2014 |
Sopik V, Narod SA. Breast-cancer risk in families with mutations in PALB2. The New England Journal of Medicine. 371: 1650. PMID 25337757 DOI: 10.1056/NEJMc1410673#SA1 |
0.554 |
|
| 2014 |
Zhang WW, Feng Z, Narod SA. Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia. Journal of Biomedical Research. 28: 339-48. PMID 25332705 DOI: 10.7555/Jbr.28.20140008 |
0.341 |
|
| 2014 |
Narod SA, Sun P, Wall C, Baines C, Miller AB. Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age. Current Oncology (Toronto, Ont.). 21: 217-21. PMID 25302030 DOI: 10.3747/Co.21.2067 |
0.554 |
|
| 2014 |
Narod SA. Reflections on screening mammography and the early detection of breast cancer: A Countercurrents Series. Current Oncology (Toronto, Ont.). 21: 210-4. PMID 25301304 DOI: 10.3747/Co.21.2068 |
0.534 |
|
| 2014 |
Satkunasivam R, Zhang W, Trachtenberg J, Toi A, Yu C, Diamandis E, Kattan MW, Narod SA, Nam RK. Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy. Springerplus. 3: 295. PMID 25279276 DOI: 10.1186/2193-1801-3-295 |
0.336 |
|
| 2014 |
Kotsopoulos J, Prescott J, De Vivo I, Fan I, Mclaughlin J, Rosen B, Risch H, Sun P, Narod SA. Telomere length and mortality following a diagnosis of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2603-6. PMID 25159293 DOI: 10.1158/1055-9965.Epi-14-0885 |
0.339 |
|
| 2014 |
Byrski T, Huzarski T, Dent R, Marczyk E, Jasiowka M, Gronwald J, Jakubowicz J, Cybulski C, Wisniowski R, Godlewski D, Lubinski J, Narod SA. Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients Breast Cancer Research and Treatment. 147: 401-405. PMID 25129345 DOI: 10.1007/S10549-014-3100-X |
0.626 |
|
| 2014 |
Singer CF, Rappaport-Fuerhauser C, Sopik V, Narod SA. Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer. Clinical Genetics. 88: 187-9. PMID 25112434 DOI: 10.1111/Cge.12478 |
0.616 |
|
| 2014 |
Akbari MR, Wallis CJ, Toi A, Trachtenberg J, Sun P, Narod SA, Nam RK. The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer. British Journal of Cancer. 111: 1238-40. PMID 25101567 DOI: 10.1038/Bjc.2014.428 |
0.508 |
|
| 2014 |
Giannakeas V, Lubinski J, Gronwald J, Moller P, Armel S, Lynch HT, Foulkes WD, Kim-Sing C, Singer C, Neuhausen SL, Friedman E, Tung N, Senter L, Sun P, Narod SA. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study. Breast Cancer Research and Treatment. 147: 113-8. PMID 25082516 DOI: 10.1007/S10549-014-3063-Y |
0.662 |
|
| 2014 |
Hernandez RK, Quach D, Wade SW, Pirolli M, Quigley J, Narod SA, Liede A. Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States. Breast Cancer Research and Treatment. 146: 637-46. PMID 25053278 DOI: 10.1007/S10549-014-3052-1 |
0.511 |
|
| 2014 |
Rosen B, Laframboise S, Ferguson S, Dodge J, Bernardini M, Murphy J, Segev Y, Sun P, Narod SA. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer. Gynecologic Oncology. 134: 462-7. PMID 25026637 DOI: 10.1016/J.Ygyno.2014.07.004 |
0.377 |
|
| 2014 |
Kotsopoulos J, Zhang S, Akbari M, Salmena L, Llacuachaqui M, Zeligs M, Sun P, Narod SA. BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane. British Journal of Cancer. 111: 1269-74. PMID 25025957 DOI: 10.1038/Bjc.2014.391 |
0.463 |
|
| 2014 |
Gronwald J, Robidoux A, Kim-Sing C, Tung N, Lynch HT, Foulkes WD, Manoukian S, Ainsworth P, Neuhausen SL, Demsky R, Eisen A, Singer CF, Saal H, Senter L, Eng C, ... ... Narod SA, et al. Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 146: 421-7. PMID 24951267 DOI: 10.1007/S10549-014-3026-3 |
0.646 |
|
| 2014 |
Cybulski C, Nazarali S, Narod SA. Multiple primary cancers as a guide to heritability. International Journal of Cancer. 135: 1756-63. PMID 24945890 DOI: 10.1002/Ijc.28988 |
0.577 |
|
| 2014 |
Dent R, Valentini A, Hanna W, Rawlinson E, Rakovitch E, Sun P, Narod SA. Factors associated with breast cancer mortality after local recurrence. Current Oncology (Toronto, Ont.). 21: e418-25. PMID 24940101 DOI: 10.3747/Co.21.1563 |
0.494 |
|
| 2014 |
Narod SA, Rakovitch E. A comparison of the risks of in-breast recurrence after a diagnosis of DCIS or early invasive breast cancer Current Oncology. 21: 119-124. PMID 24940092 DOI: 10.3747/Co.21.1892 |
0.62 |
|
| 2014 |
Vyarvelska I, Rosen B, Narod SA. Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers? Gynecologic Oncology. 134: 219-21. PMID 24887353 DOI: 10.1016/J.Ygyno.2014.05.020 |
0.463 |
|
| 2014 |
Shai A, Segev Y, Narod SA. Genetics of endometrial cancer. Familial Cancer. 13: 499-505. PMID 24838932 DOI: 10.1007/s10689-014-9722-7 |
0.52 |
|
| 2014 |
Savanevich A, Oszurek O, Lubiński J, Cybulski C, Dębniak T, Narod SA, Gronwald J. BRCA1 founder mutations compared to ovarian cancer in Belarus. Familial Cancer. 13: 445-7. PMID 24770866 DOI: 10.1007/S10689-014-9721-8 |
0.592 |
|
| 2014 |
Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Sun P, Narod SA, Schildkraut J. Risk factors for ovarian cancers with and without microsatellite instability. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 664-9. PMID 24755492 DOI: 10.1097/IGC.0000000000000134 |
0.376 |
|
| 2014 |
Hernández JE, Llacuachaqui M, Palacio GV, Figueroa JD, Madrid J, Lema M, Royer R, Li S, Larson G, Weitzel JN, Narod SA. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia. Hereditary Cancer in Clinical Practice. 12: 11. PMID 24742220 DOI: 10.1186/1897-4287-12-11 |
0.635 |
|
| 2014 |
Kotsopoulos J, Metcalfe K, Alston J, Nikitina D, Ginsburg O, Eisen A, Demsky R, Akbari M, Zbuk K, Narod SA. Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'. Bmc Cancer. 14: 221. PMID 24667084 DOI: 10.1186/1471-2407-14-221 |
0.79 |
|
| 2014 |
Nazarali SA, Narod SA. Tamoxifen for women at high risk of breast cancer. Breast Cancer (Dove Medical Press). 6: 29-36. PMID 24648767 DOI: 10.2147/BCTT.S43763 |
0.552 |
|
| 2014 |
McMullin RP, Wittner BS, Yang C, Denton-Schneider BR, Hicks D, Singavarapu R, Moulis S, Lee J, Akbari MR, Narod SA, Aldape KD, Steeg PS, Ramaswamy S, Sgroi DC. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast Cancer Research : Bcr. 16: R25. PMID 24625110 DOI: 10.1186/Bcr3625 |
0.568 |
|
| 2014 |
Lee JH, Cragun D, Thompson Z, Coppola D, Nicosia SV, Akbari M, Zhang S, McLaughlin J, Narod S, Schildkraut J, Sellers TA, Pal T. Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer. Genetic Testing and Molecular Biomarkers. 18: 229-35. PMID 24592941 DOI: 10.1089/Gtmb.2013.0393 |
0.308 |
|
| 2014 |
Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, ... ... Narod SA, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1547-53. PMID 24567435 DOI: 10.1200/Jco.2013.53.2820 |
0.744 |
|
| 2014 |
Huzarski T, Cybulski C, Wokolorczyk D, Jakubowska A, Byrski T, Gronwald J, Domagała P, Szwiec M, Godlewski D, Kilar E, Marczyk E, Siołek M, Wiśniowski R, Janiszewska H, Surdyka D, ... ... Narod SA, et al. Survival from breast cancer in patients with CHEK2 mutations. Breast Cancer Research and Treatment. 144: 397-403. PMID 24557336 DOI: 10.1007/S10549-014-2865-2 |
0.623 |
|
| 2014 |
Baltzer HL, Alonzo-Proulx O, Mainprize JG, Yaffe MJ, Metcalfe KA, Narod SA, Warner E, Semple JL. MRI volumetric analysis of breast fibroglandular tissue to assess risk of the spared nipple in BRCA1 and BRCA2 mutation carriers. Annals of Surgical Oncology. 21: 1583-8. PMID 24526546 DOI: 10.1245/S10434-014-3532-X |
0.67 |
|
| 2014 |
Kong I, Narod SA, Taylor C, Paszat L, Saskin R, Nofech-Moses S, Thiruchelvam D, Hanna W, Pignol JP, Sengupta S, Elavathil L, Jani PA, Done SJ, Metcalfe S, Rakovitch E. Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis. Current Oncology (Toronto, Ont.). 21: e96-e104. PMID 24523627 DOI: 10.3747/Co.21.1604 |
0.417 |
|
| 2014 |
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. Bmj (Clinical Research Ed.). 348: g366. PMID 24519768 DOI: 10.1097/Ogx.0000000000000066 |
0.535 |
|
| 2014 |
Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, Kim-Sing C, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. Bmj (Clinical Research Ed.). 348: g226. PMID 24519767 DOI: 10.1136/Bmj.G226 |
0.804 |
|
| 2014 |
Narod SA. Bilateral breast cancers. Nature Reviews. Clinical Oncology. 11: 157-66. PMID 24492834 DOI: 10.1038/Nrclinonc.2014.3 |
0.66 |
|
| 2014 |
Kharazmi E, Chen T, Narod S, Sundquist K, Hemminki K. Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study Breast Cancer Research and Treatment. 144: 185-192. PMID 24487690 DOI: 10.1007/S10549-014-2848-3 |
0.589 |
|
| 2014 |
Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF, Eng C, Neuhausen SL, Karlan B, Kim-Sing C, Huzarski T, Gronwald J, McCuaig J, Senter L, Tung N, Ghadirian P, ... ... Narod SA, et al. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Research and Treatment. 143: 579-86. PMID 24458845 DOI: 10.1007/S10549-013-2823-4 |
0.559 |
|
| 2014 |
Nam RK, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, Chang M, Kulkarni GS, Lee Y, Kodama RT, Narod SA. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. The Lancet. Oncology. 15: 223-31. PMID 24440474 DOI: 10.1016/S1470-2045(13)70606-5 |
0.366 |
|
| 2014 |
Phelan CM, Iqbal J, Lynch HT, Lubinski J, Gronwald J, Moller P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen SL, Senter L, Singer CF, Ainsworth P, Kim-Sing C, ... ... Narod SA, et al. Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study. British Journal of Cancer. 110: 530-4. PMID 24292448 DOI: 10.1038/Bjc.2013.741 |
0.441 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Narod SA, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.434 |
|
| 2014 |
Akbari MR, Lepage P, Rosen B, McLaughlin J, Risch H, Minden M, Narod SA. PPM1D mutations in circulating white blood cells and the risk for ovarian cancer. Journal of the National Cancer Institute. 106: djt323. PMID 24262437 DOI: 10.1093/Jnci/Djt323 |
0.594 |
|
| 2014 |
Finch A, Bacopulos S, Rosen B, Fan I, Bradley L, Risch H, McLaughlin JR, Lerner-Ellis J, Narod SA. Preventing ovarian cancer through genetic testing: a population-based study. Clinical Genetics. 86: 496-9. PMID 24199689 DOI: 10.1111/Cge.12313 |
0.572 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Narod SA, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.375 |
|
| 2014 |
Kashyap A, Kluźniak W, Wokołorczyk D, Goła̧b A, Sikorski A, Słojewski M, Gliniewicz B, Świtała J, Borkowski T, Borkowski A, Antczak A, Wojnar Ł, Przybyła J, Sosnowski M, Małkiewicz B, ... ... Narod SA, et al. The presence of prostate cancer at biopsy is predicted by a number of genetic variants International Journal of Cancer. 134: 1139-1146. PMID 24037955 DOI: 10.1002/Ijc.28447 |
0.357 |
|
| 2014 |
Pal T, Bonner D, Cragun D, Johnson S, Akbari M, Servais L, Narod S, Vadaparampil S. BRCA sequencing and large rearrangement testing in young Black women with breast cancer. Journal of Community Genetics. 5: 157-65. PMID 24013928 DOI: 10.1007/S12687-013-0166-9 |
0.635 |
|
| 2014 |
Metcalfe KA, Kim-Sing C, Ghadirian P, Sun P, Narod SA. Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 85: 21-30. PMID 23859469 DOI: 10.1111/Cge.12233 |
0.745 |
|
| 2014 |
Ghadirian P, Robidoux A, Nassif E, Martin G, Potvin C, Patocskai E, Younan R, Larouche N, Venne A, Zhang S, Royer R, Narod SA. Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal. Clinical Genetics. 85: 31-5. PMID 23621881 DOI: 10.1111/Cge.12174 |
0.651 |
|
| 2014 |
Laitman Y, Vaisman Y, Feldman D, Helpman L, Gitly M, Paluch Shimon S, Berger R, Cohen L, Narod SA, Friedman E. Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers. Clinical Genetics. 85: 68-71. PMID 23517234 DOI: 10.1111/Cge.12149 |
0.602 |
|
| 2014 |
Akbari MR, Donenberg T, Lunn J, Curling D, Turnquest T, Krill-Jackson E, Zhang S, Narod SA, Hurley J. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clinical Genetics. 85: 64-7. PMID 23458327 DOI: 10.1111/Cge.12132 |
0.598 |
|
| 2014 |
Narod SA, Tung N, Lubinski J, Huzarski T, Robson M, Lynch HT, Neuhausen SL, Ghadirian P, Kim-Sing C, Sun P, Foulkes WD. A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers Current Oncology. 21: 64-68. DOI: 10.3747/Co.21.1656 |
0.664 |
|
| 2014 |
Villarreal-Garza CM, Weitzel JN, Sifuentes E, Llacuachaqui M, Herzog J, Castillo D, Royer R, Magallanes-Hoyos MC, Alvarez-Gómez RM, Gallardo L, Lara-Medina F, Herrera LA, Narod S. Founder effect and a high prevalence of BRCA1 mutations among young Mexican triple-negative breast cancer (TNBC) patients. Journal of Clinical Oncology. 32: 1522-1522. DOI: 10.1200/Jco.2014.32.15_Suppl.1522 |
0.61 |
|
| 2014 |
Metcalfe KA, Lynch HT, Snyder CL, Foulkes W, Tung NM, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Sun P, Narod S. The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology. 32: 1507-1507. DOI: 10.1200/Jco.2014.32.15_Suppl.1507 |
0.819 |
|
| 2014 |
Pal T, Bonner D, Cragun D, Johnson S, Akbari MR, Servais L, Narod S, Vadaparampil ST. Proportion of BRCA mutation frequency in young black women with breast cancer. Journal of Clinical Oncology. 32: 1506-1506. DOI: 10.1200/Jco.2014.32.15_Suppl.1506 |
0.667 |
|
| 2014 |
Holter S, Borgida A, Dodd A, Narod S, Akbari M, Moore M, Gallinger S. Abstract 12: Germline BRCA mutations in an unselected cohort of patients with pancreatic adenocarcinoma Cancer Research. 74: 12-12. DOI: 10.1158/1538-7445.Cansusc14-12 |
0.591 |
|
| 2014 |
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty-five-year follow-up for breast cancer incidence and mortality of the canadian national breast screening study: Randomized screening trial Obstetrical and Gynecological Survey. 69: 329-330. DOI: 10.1097/OGX.0000000000000066 |
0.398 |
|
| 2014 |
Narod SA. Modern approaches to cancer prevention: Universal or personal? Journal of Cancer Policy. 2: 93-96. DOI: 10.1016/J.Jcpo.2014.05.002 |
0.392 |
|
| 2014 |
Lalani N, Paszat L, Nofech-Mozes R, Narod S, Hanna W, Thiruchelvam D, Tuck A, Sengupta S, Elavathil L, Jani P, Done S, Miller N, Youngson B, Bonin M, Rakovitch E. Hypofractionated Radiation Therapy for Ductal Carcinoma in Situ of the Breast International Journal of Radiation Oncology*Biology*Physics. 90: S134-S135. DOI: 10.1016/J.Ijrobp.2014.05.587 |
0.37 |
|
| 2013 |
Galor A, Cybulski C, Lubiński J, Narod SA, Gronwald J. Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephone. Hereditary Cancer in Clinical Practice. 11: 17. PMID 24325841 DOI: 10.1186/1897-4287-11-17 |
0.35 |
|
| 2013 |
Valentini A, Lubinski J, Byrski T, Ghadirian P, Moller P, Lynch HT, Ainsworth P, Neuhausen SL, Weitzel J, Singer CF, Olopade OI, Saal H, Lyonnet DS, Foulkes WD, Kim-Sing C, ... ... Narod SA, et al. The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Research and Treatment. 142: 177-85. PMID 24136669 DOI: 10.1007/S10549-013-2729-1 |
0.647 |
|
| 2013 |
Antczak A, Kluźniak W, Wokołorczyk D, Kashyap A, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Deogonekbniak T, Masojć B, Górski B, Gromowski T, Nagorna A, Gołaogonekb A, Sikorski A, ... ... Narod SA, et al. A common nonsense mutation of the BLM gene and prostate cancer risk and survival Gene. 532: 173-176. PMID 24096176 DOI: 10.1016/J.Gene.2013.09.079 |
0.509 |
|
| 2013 |
Huzarski T, Cybulski C, Jakubowska A, Byrski T, Gronwald J, Domagała P, Szwiec M, Godlewski D, Kilar E, Marczyk E, Siołek M, Gorski B, Wiśniowski R, Janiszewska H, Surdyka D, ... ... Narod SA, et al. Clinical characteristics of breast cancer in patients with an NBS1 mutation Breast Cancer Research and Treatment. 141: 471-476. PMID 24072268 DOI: 10.1007/S10549-013-2692-X |
0.575 |
|
| 2013 |
Valentini A, Finch A, Lubinski J, Byrski T, Ghadirian P, Kim-Sing C, Lynch HT, Ainsworth PJ, Neuhausen SL, Greenblatt E, Singer C, Sun P, Narod SA. Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3914-9. PMID 23980083 DOI: 10.1200/JCO.2012.47.7893 |
0.575 |
|
| 2013 |
Huzarski T, Byrski T, Gronwald J, Górski B, Domagala P, Cybulski C, Oszurek O, Szwiec M, Gugala K, Stawicka M, Morawiec Z, Mierzwa T, Janiszewska H, Kilar E, Marczyk E, ... ... Narod SA, et al. Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3191-6. PMID 23940229 DOI: 10.1200/Jco.2012.45.3571 |
0.603 |
|
| 2013 |
Narod SA, Iqbal J, Jakubowska A, Huzarski T, Sun P, Cybulski C, Gronwald J, Byrski T, Lubinski J. Are two-centimeter breast cancers large or small? Current Oncology (Toronto, Ont.). 20: 205-11. PMID 23904761 DOI: 10.3747/Co.20.1364 |
0.576 |
|
| 2013 |
Tryggvadottir L, Olafsdottir EJ, Olafsdottir GH, Sigurdsson H, Johannsson OT, Bjorgvinsson E, Alexiusdottir K, Stefansson OA, Agnarsson BA, Narod SA, Eyfjord JE, Jonasson JG. Tumour diploidy and survival in breast cancer patients with BRCA2 mutations. Breast Cancer Research and Treatment. 140: 375-384. PMID 23857704 DOI: 10.1007/S10549-013-2637-4 |
0.617 |
|
| 2013 |
Metcalfe KA, Poll A, Royer R, Nanda S, Llacuachaqui M, Sun P, Narod SA. A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing. British Journal of Cancer. 109: 777-9. PMID 23778531 DOI: 10.1038/Bjc.2013.309 |
0.677 |
|
| 2013 |
Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Ping S, Narod SA, Schildkraut J. Risk factors for ovarian cancers with and without microsatellite instability. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 1010-5. PMID 23748177 DOI: 10.1097/Igc.0B013E31829A5527 |
0.389 |
|
| 2013 |
Semple J, Metcalfe KA, Lynch HT, Kim-Sing C, Senter L, Pal T, Ainsworth P, Lubinski J, Tung N, Eng C, Gilchrist D, Blum J, Neuhausen SL, Singer CF, Ghadirian P, ... ... Narod SA, et al. International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. Annals of Surgical Oncology. 20: 3817-22. PMID 23740344 DOI: 10.1245/S10434-013-3040-4 |
0.802 |
|
| 2013 |
Narod SA. Salpingectomy to prevent ovarian cancer: A Countercurrents Series. Current Oncology. 20: 145-147. PMID 23737681 DOI: 10.3747/Co.20.1471 |
0.646 |
|
| 2013 |
Cybulski C, Wokołorczyk D, Kluzńiak W, Kashyap A, Goła̧b A, Słojewski M, Sikorski A, Puszyński M, Soczawa M, Borkowski T, Borkowski A, Antczak A, Przybyła J, Sosnowski M, Małkiewicz B, ... ... Narod SA, et al. A personalised approach to prostate cancer screening based on genotyping of risk founder alleles British Journal of Cancer. 108: 2601-2609. PMID 23722471 DOI: 10.1038/Bjc.2013.261 |
0.427 |
|
| 2013 |
Rakovitch E, Narod SA, Nofech-Moses S, Hanna W, Thiruchelvam D, Saskin R, Taylor C, Tuck A, Youngson B, Miller N, Done SJ, Sengupta S, Elavathil L, Jani PA, Bonin M, et al. Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis. International Journal of Radiation Oncology, Biology, Physics. 86: 491-7. PMID 23708085 DOI: 10.1016/J.Ijrobp.2013.02.031 |
0.374 |
|
| 2013 |
Møller P, Stormorken A, Jonsrud C, Holmen MM, Hagen AI, Clark N, Vabø A, Sun P, Narod SA, Mæhle L. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program. Breast Cancer Research and Treatment. 139: 155-61. PMID 23615785 DOI: 10.1007/S10549-013-2540-Z |
0.64 |
|
| 2013 |
Segev Y, Iqbal J, Lubinski J, Gronwald J, Lynch HT, Moller P, Ghadirian P, Rosen B, Tung N, Kim-Sing C, Foulkes WD, Neuhausen SL, Senter L, Singer CF, Karlan B, ... ... Narod SA, et al. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. Gynecologic Oncology. 130: 127-31. PMID 23562522 DOI: 10.1016/J.Ygyno.2013.03.027 |
0.539 |
|
| 2013 |
Narod SA. Countercurrents: A new kind of breast cancer gene mutation: A Countercurrents Series. Current Oncology. 20: 88-89. PMID 23559870 DOI: 10.3747/Co.20.1403 |
0.619 |
|
| 2013 |
Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Narod SA, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212 |
0.588 |
|
| 2013 |
Akbari MR, Anderson LN, Buchanan DD, Clendenning M, Jenkins MA, Win AK, Hopper JL, Giles GG, Nam R, Narod S, Gallinger S, Cleary SP. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer. Cancer Epidemiology. 37: 424-7. PMID 23541221 DOI: 10.1016/J.Canep.2013.03.003 |
0.501 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Narod SA, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.495 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Narod SA, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.361 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Narod SA, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.465 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Narod SA, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.341 |
|
| 2013 |
Jaworska K, Gupta S, Durda K, Muszyńska M, Sukiennicki G, Jaworowska E, Grodzki T, Sulikowski M, Waloszczyk P, Woloszczyk P, Wójcik J, Lubiński J, Cybulski C, Dębniak T, Lener M, ... ... Narod SA, et al. A low selenium level is associated with lung and laryngeal cancers. Plos One. 8: e59051. PMID 23516596 DOI: 10.1371/Journal.Pone.0059051 |
0.441 |
|
| 2013 |
Pal T, Vadaparampil S, Kim J, Xu Y, Friedman S, Narod SA, Metcalfe K. Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers. Familial Cancer. 12: 615-9. PMID 23504063 DOI: 10.1007/S10689-013-9624-0 |
0.66 |
|
| 2013 |
Rakovitch E, Nofech-Mozes S, Narod SA, Hanna W, Thiruchelvam D, Saskin R, Taylor C, Tuck A, Sengupta S, Elavathil L, Jani PA, Done SJ, Miller N, Youngson B, Kong I, et al. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Research and Treatment. 138: 581-90. PMID 23456231 DOI: 10.1007/S10549-013-2455-8 |
0.483 |
|
| 2013 |
Narod SA. Breast cancer and the environment: what is left to learn?: A Countercurrents Series. Current Oncology. 20: 8-9. PMID 23443916 DOI: 10.3747/Co.20.1326 |
0.597 |
|
| 2013 |
Gupta IR, Baldwin C, Auguste D, Ha KC, El Andalousi J, Fahiminiya S, Bitzan M, Bernard C, Akbari MR, Narod SA, Rosenblatt DS, Majewski J, Takano T. ARHGDIA: a novel gene implicated in nephrotic syndrome. Journal of Medical Genetics. 50: 330-8. PMID 23434736 DOI: 10.1136/Jmedgenet-2012-101442 |
0.312 |
|
| 2013 |
Finch A, Valentini A, Greenblatt E, Lynch HT, Ghadirian P, Armel S, Neuhausen SL, Kim-Sing C, Tung N, Karlan B, Foulkes WD, Sun P, Narod S. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation Fertility and Sterility. 99: 1724-1728. PMID 23414920 DOI: 10.1016/j.fertnstert.2013.01.109 |
0.361 |
|
| 2013 |
Xu Y, Diao L, Chen Y, Liu Y, Wang C, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Deng D, Narod SA, Xie Y. Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 1498-505. PMID 23406733 DOI: 10.1093/Annonc/Mdt011 |
0.526 |
|
| 2013 |
Metcalfe KA, Quan ML, Eisen A, Cil T, Sun P, Narod SA. The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception. Cancer. 119: 1722-8. PMID 23400407 DOI: 10.1002/Cncr.27924 |
0.772 |
|
| 2013 |
Narod SA, Metcalfe K, Lynch HT, Ghadirian P, Robidoux A, Tung N, Gaughan E, Kim-Sing C, Olopade OI, Foulkes WD, Robson M, Offit K, Jakubowska A, Byrski T, Huzarski T, et al. Should all BRCA1 mutation carriers with stage i breast cancer receive chemotherapy? Breast Cancer Research and Treatment. 138: 273-279. PMID 23381743 DOI: 10.1007/S10549-013-2429-X |
0.798 |
|
| 2013 |
García-Jiménez L, Gutiérrez-Espeleta G, Narod SA. [Descriptive epidemiology and molecular genetics of hereditary breast cancer in Costa Rica]. Revista De Biologia Tropical. 60: 1663-8. PMID 23342520 |
0.607 |
|
| 2013 |
Kluźniak W, Wokołorczyk D, Kashyap A, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dȩbniak T, Goła̧b A, Gliniewicz B, Sikorski A, Świtała J, Borkowski T, Borkowski A, Antczak A, ... ... Narod SA, et al. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland Prostate. 73: 542-548. PMID 23334858 DOI: 10.1002/Pros.22594 |
0.459 |
|
| 2013 |
Pal T, Bonner D, Kim J, Monteiro AN, Kessler L, Royer R, Narod SA, Vadaparampil ST. Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics. The Breast Journal. 19: 189-92. PMID 23320992 DOI: 10.1111/Tbj.12083 |
0.66 |
|
| 2013 |
Teodorczyk U, Cybulski C, Woko?orczyk D, Jakubowska A, Starzy?ska T, Lawniczak M, Domaga?a P, Ferenc K, Marlicz K, Banaszkiewicz Z, Wi?niowski R, Narod SA, Lubi?ski J. The risk of gastric cancer in carriers of CHEK2 mutations. Familial Cancer. 12: 473-8. PMID 23296741 DOI: 10.1007/S10689-012-9599-2 |
0.514 |
|
| 2013 |
McLaughlin JR, Rosen B, Moody J, Pal T, Fan I, Shaw PA, Risch HA, Sellers TA, Sun P, Narod SA. Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2. Journal of the National Cancer Institute. 105: 141-8. PMID 23257159 DOI: 10.1093/Jnci/Djs494 |
0.567 |
|
| 2013 |
Cybulski C, Wokołorczyk D, Kluźniak W, Jakubowska A, Górski B, Gronwald J, Huzarski T, Kashyap A, Byrski T, Dȩbniak T, Goła̧b A, Gliniewicz B, Sikorski A, Świtała J, Borkowski T, ... ... Narod SA, et al. An inherited NBN mutation is associated with poor prognosis prostate cancer British Journal of Cancer. 108: 461-468. PMID 23149842 DOI: 10.1038/Bjc.2012.486 |
0.494 |
|
| 2013 |
Senst N, Llacuachaqui M, Lubinski J, Lynch H, Armel S, Neuhausen S, Ghadirian P, Sun P, Narod S. Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation Clinical Genetics. 84: 43-46. PMID 23066998 DOI: 10.1111/Cge.12037 |
0.618 |
|
| 2013 |
Narod SA, Moody JR, Rosen B, Fan I, Risch A, Sun P, McLaughlin JR. Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations. Clinical Genetics. 83: 232-7. PMID 22680617 DOI: 10.1111/J.1399-0004.2012.01906.X |
0.493 |
|
| 2013 |
Narod SA. A model for breast cancer risk based on stem-cell theory. Current Oncology (Toronto, Ont.). 19: 9-11. PMID 22328835 DOI: 10.3747/Co.19.1003 |
0.536 |
|
| 2013 |
Møller P, Maehle L, Vabø A, Clark N, Sun P, Narod SA. Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway. Clinical Genetics. 83: 88-91. PMID 22320316 DOI: 10.1111/J.1399-0004.2012.01855.X |
0.645 |
|
| 2013 |
Finch A, Metcalfe KA, Chiang J, Elit L, McLaughlin J, Springate C, Esplen MJ, Demsky R, Murphy J, Rosen B, Narod SA. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation. Psycho-Oncology. 22: 212-9. PMID 21913283 DOI: 10.1002/Pon.2041 |
0.632 |
|
| 2013 |
Jaworska K, Gupta S, Durda K, Muszyńska M, Sukiennicki G, Jaworowska E, Grodzki T, Sulikowski M, Waloszczyk P, Wójcik J, Lubiński J, Cybulski C, Dębniak T, Lener M, Morawski AW, ... ... Narod SA, et al. Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers. Plos One. 8. DOI: 10.1371/Annotation/F777Aaec-B6B8-4480-9Cce-18E0F1B8E5D5 |
0.332 |
|
| 2013 |
Schütz E, Akbari MR, Beck J, Urnovitz HB, Zhang W, Mitchell WM, Nam R, Narod S. Quantifying copy number variations in cell-free DNA for potential clinical utility from a large prostate cancer cohort. Journal of Clinical Oncology. 31: 5072-5072. DOI: 10.1200/Jco.2013.31.15_Suppl.5072 |
0.332 |
|
| 2013 |
Baltzer H, Alonzo O, Yaffe M, Narod S, Metcalfe KA, Warner E, Semple J. MRI volumetric analysis of fibroglandular tissue to assess risk of the spared nipple in BRCA 1/2 patients who are considering prophylactic nipple-sparing mastectomy. Journal of Clinical Oncology. 31: 1507-1507. DOI: 10.1200/Jco.2013.31.15_Suppl.1507 |
0.694 |
|
| 2013 |
Jim H, Tyrer J, Lin H, Han G, Qu X, Goode EL, Chen Z, Tsai Y, Cunningham JM, Iversen E, Ramus S, Berchuck A, Schildkraut J, Monteiro A, Gayther S, ... Narod SA, et al. Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness. Cancer Research. 73: 4850-4850. DOI: 10.1158/1538-7445.Am2013-4850 |
0.396 |
|
| 2013 |
Lin H, Tsai Y, Chen YA, Chen Z, Qu X, Goode EL, Schildkraut J, Iversen E, Narod SA, Sellers TA, Phelan CM. Abstract 4839: SNP-SNP interactions in mitochondria-related pathways are associated with invasive Epithelial Ovarian Cancer (EOC) risk . Cancer Research. 73: 4839-4839. DOI: 10.1158/1538-7445.Am2013-4839 |
0.307 |
|
| 2013 |
Chen YA, Chen Z, Permuth-Wey J, Tsai Y, Lin H, Qu X, Lawrenson K, Fenstermacher D, Phelan CM, Monteiro A, Gayther SA, Narod SA, Sutphen R, Birrer MJ, Wentzensen N, et al. Abstract 4579: Variants in long non-coding RNAs are associated with epithelial ovarian cancer risk in a pooled analysis of three genome-wide association studies. Cancer Research. 73: 4579-4579. DOI: 10.1158/1538-7445.Am2013-4579 |
0.369 |
|
| 2013 |
Chornokur G, Tyrer J, Lin H, Han G, Qu X, Zhihua C, Tsai Y, Goode EL, Cunningham JM, Iversen E, Ramus SJ, Berchuk A, Schildkraut JM, Monteiro A, Gayther SA, ... Narod SA, et al. Abstract 3644: Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype. Cancer Research. 73: 3644-3644. DOI: 10.1158/1538-7445.Am2013-3644 |
0.43 |
|
| 2013 |
Amankwah EK, Tyrer J, Lin H, Tsai Y, Chen Z, Han G, Qu X, Goode E, Cunninghan J, Iverson E, Ramus S, Berchuck A, Schildkraut J, Monteiro A, Gayther S, ... Narod S, et al. Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry. Cancer Research. 73: 1352-1352. DOI: 10.1158/1538-7445.Am2013-1352 |
0.46 |
|
| 2013 |
Segev Y, Iqbal J, Ping S, Rosen B, Narod S. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations Gynecologic Oncology. 130: e42. DOI: 10.1016/J.Ygyno.2013.04.159 |
0.526 |
|
| 2012 |
Coppola D, Nicosia SV, Doty A, Sellers TA, Lee JH, Fulp J, Thompson Z, Galeb S, McLaughlin J, Narod SA, Schildkraut J, Pal T. Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer. Anticancer Research. 32: 4963-9. PMID 23155266 |
0.325 |
|
| 2012 |
Narod SA. Tumour size predicts long-term survival among women with lymph node-positive breast cancer. Current Oncology. 19: 249-253. PMID 23144572 DOI: 10.3747/Co.19.1043 |
0.521 |
|
| 2012 |
Iqbal J, Ragone A, Lubinski J, Lynch HT, Moller P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen SL, Senter L, Singer CF, Ainsworth P, Kim-Sing C, Tung N, ... ... Narod SA, et al. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 107: 2005-9. PMID 23099806 DOI: 10.1038/bjc.2012.483 |
0.464 |
|
| 2012 |
Akbari MR, Kluźniak W, Rodin R, Li S, Wokołorczyk D, Royer R, Kashyap A, Menkiszak J, Lubinski J, Narod SA, Cybulski C. The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer Breast Cancer Research and Treatment. 136: 907-909. PMID 23099437 DOI: 10.1007/S10549-012-2295-Y |
0.681 |
|
| 2012 |
Pal T, Akbari MR, Sun P, Lee JH, Fulp J, Thompson Z, Coppola D, Nicosia S, Sellers TA, McLaughlin J, Risch HA, Rosen B, Shaw P, Schildkraut J, Narod SA. Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer. British Journal of Cancer. 107: 1783-90. PMID 23047549 DOI: 10.1038/bjc.2012.452 |
0.458 |
|
| 2012 |
Becker T, Lipscombe L, Narod S, Simmons C, Anderson GM, Rochon PA. Systematic review of bone health in older women treated with aromatase inhibitors for early-stage breast cancer Journal of the American Geriatrics Society. 60: 1761-1767. PMID 22985145 DOI: 10.1111/J.1532-5415.2012.04107.X |
0.498 |
|
| 2012 |
Finch A, Evans G, Narod SA. BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations. Women's Health (London, England). 8: 543-55. PMID 22934728 DOI: 10.2217/Whe.12.41 |
0.561 |
|
| 2012 |
Timofeeva MN, Hung RJ, Rafnar T, Christiani DC, Field JK, Bickeböller H, Risch A, McKay JD, Wang Y, Dai J, Gaborieau V, McLaughlin J, Brenner D, Narod SA, Caporaso NE, et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Human Molecular Genetics. 21: 4980-95. PMID 22899653 DOI: 10.1093/Hmg/Dds334 |
0.347 |
|
| 2012 |
Narod SA. Is breast cancer staging obsolete Current Oncology. 19: 195-196. PMID 22876144 DOI: 10.3747/Co.19.1158 |
0.423 |
|
| 2012 |
McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D. Routine TP53 testing for breast cancer under age 30: ready for prime time? Familial Cancer. 11: 607-13. PMID 22851211 DOI: 10.1007/S10689-012-9557-Z |
0.639 |
|
| 2012 |
Byrski T, Dent R, Blecharz P, Foszczynska-Kloda M, Gronwald J, Huzarski T, Cybulski C, Marczyk E, Chrzan R, Eisen A, Lubinski J, Narod SA. Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer. Breast Cancer Research : Bcr. 14: R110. PMID 22817698 DOI: 10.1186/Bcr3231 |
0.577 |
|
| 2012 |
Narod SA. Supplementary imaging for breast cancer screening in high-risk women. Jama. 308: 236; author reply 23. PMID 22797634 DOI: 10.1001/Jama.2012.7547 |
0.572 |
|
| 2012 |
Narod SA. Ten types of breast cancer? Lancet (London, England). 380: 1212-3. PMID 22781491 DOI: 10.1016/S0140-6736(12)60781-8 |
0.577 |
|
| 2012 |
Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, Narod SA, Nam RK. Association between germline HOXB13 G84E mutation and risk of prostate cancer. Journal of the National Cancer Institute. 104: 1260-2. PMID 22781434 DOI: 10.1093/Jnci/Djs288 |
0.41 |
|
| 2012 |
Kotsopoulos J, Kim YI, Narod SA. Folate and breast cancer: what about high-risk women? Cancer Causes & Control : Ccc. 23: 1405-20. PMID 22767328 DOI: 10.1007/S10552-012-0022-Y |
0.639 |
|
| 2012 |
Narod SA. Breast cancer in young women. Nature Reviews. Clinical Oncology. 9: 460-70. PMID 22733233 DOI: 10.1038/Nrclinonc.2012.102 |
0.641 |
|
| 2012 |
Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Narod SA, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229 |
0.623 |
|
| 2012 |
Kotsopoulos J, Moody JR, Fan I, Rosen B, Risch HA, McLaughlin JR, Sun P, Narod SA. Height, weight, BMI and ovarian cancer survival. Gynecologic Oncology. 127: 83-7. PMID 22713293 DOI: 10.1016/J.Ygyno.2012.05.038 |
0.463 |
|
| 2012 |
Weinstock C, Bigenwald R, Hochman T, Sun P, Narod SA, Warner E. Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis. Current Oncology. 19: 160-164. PMID 22670105 DOI: 10.3747/Co.19.890 |
0.609 |
|
| 2012 |
Narod SA. The tip of the iceberg: a countercurrents series. Current Oncology. 19: 129-130. PMID 22670089 DOI: 10.3747/Co.19.1103 |
0.652 |
|
| 2012 |
Passaperuma K, Warner E, Causer PA, Hill KA, Messner S, Wong JW, Jong RA, Wright FC, Yaffe MJ, Ramsay EA, Balasingham S, Verity L, Eisen A, Curpen B, Shumak R, ... ... Narod SA, et al. Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. British Journal of Cancer. 107: 24-30. PMID 22588560 DOI: 10.1038/Bjc.2012.204 |
0.526 |
|
| 2012 |
Kotsopoulos J, Sukiennicki G, Muszyńska M, Gackowski D, Ka̧klewski K, Durda K, Jaworska K, Huzarski T, Gronwald J, Byrski T, Ashuryk O, Dȩbniak T, Tołoczko-Grabarek A, Stawicka M, Godlewski D, ... ... Narod SA, et al. Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: An exploratory study Cancer Causes and Control. 23: 1065-1074. PMID 22576580 DOI: 10.1007/S10552-012-9975-0 |
0.628 |
|
| 2012 |
Kotsopoulos J, Lubinski J, Lynch HT, Kim-Sing C, Neuhausen S, Demsky R, Foulkes WD, Ghadirian P, Tung N, Ainsworth P, Senter L, Karlan B, Eisen A, Eng C, Weitzel J, ... ... Narod SA, et al. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Cancer Epidemiology Biomarkers and Prevention. 21: 1089-1096. PMID 22564871 DOI: 10.1158/1055-9965.Epi-12-0201 |
0.676 |
|
| 2012 |
Narod SA, Valentini A, Nofech-Mozes S, Sun P, Hanna W. Tumour characteristics among women with very low-risk breast cancer. Breast Cancer Research and Treatment. 134: 1241-6. PMID 22547106 DOI: 10.1007/S10549-012-2065-X |
0.592 |
|
| 2012 |
Narod SA. Disappearing breast cancers. Current Oncology (Toronto, Ont.). 19: 59-60. PMID 22514490 DOI: 10.3747/Co.19.1037 |
0.606 |
|
| 2012 |
Gomes MC, Kotsopoulos J, de Almeida GL, Costa MM, Vieira R, Filho Fde A, Pitombo MB, F Leal PR, Royer R, Zhang P, Narod SA. The R337H mutation in TP53 and breast cancer in Brazil. Hereditary Cancer in Clinical Practice. 10: 3. PMID 22455664 DOI: 10.1186/1897-4287-10-3 |
0.649 |
|
| 2012 |
Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, Shoretz R, Singer CF, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, ... ... Narod SA, et al. Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1321-8. PMID 22430266 DOI: 10.1200/Jco.2011.37.8133 |
0.651 |
|
| 2012 |
Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N, Ainsworth P, Senter L, Eisen A, Eng C, Singer C, ... ... Narod SA, ... ... Narod S, et al. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Breast Cancer Research. 14. PMID 22405187 DOI: 10.1186/Bcr3138 |
0.656 |
|
| 2012 |
Salmena L, Narod S. BRCA1 Haploinsufficiency: Consequences for Breast Cancer: Women's Health. 8: 127-129. PMID 22375716 DOI: 10.2217/Whe.12.2 |
0.523 |
|
| 2012 |
Rakovitch E, Nofech-Mozes S, Hanna W, Narod S, Thiruchelvam D, Saskin R, Spayne J, Taylor C, Paszat L. HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. British Journal of Cancer. 106: 1160-1165. PMID 22361634 DOI: 10.1038/Bjc.2012.41 |
0.516 |
|
| 2012 |
McGee J, Kotsopoulos J, Lubinski J, Lynch HT, Rosen B, Tung N, Kim-Sing C, Karlan B, Foulkes WD, Ainsworth P, Ghadirian P, Senter L, Eisen A, Sun P, Narod SA, et al. Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. Obesity (Silver Spring, Md.). 20: 1288-92. PMID 22262156 DOI: 10.1038/Oby.2011.394 |
0.465 |
|
| 2012 |
Stevens KN, Kelemen LE, Wang X, Fridley BL, Vierkant RA, Fredericksen Z, Armasu SM, Tsai YY, Berchuck A, Narod SA, Phelan CM, Sutphen R, Birrer MJ, Schildkraut JM, Sellers TA, et al. Common variation in Nemo-like kinase is associated with risk of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 523-8. PMID 22253297 DOI: 10.1158/1055-9965.Epi-11-0797 |
0.461 |
|
| 2012 |
Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Research and Treatment. 133: 735-40. PMID 22240989 DOI: 10.1007/S10549-011-1941-0 |
0.814 |
|
| 2012 |
Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 16: 771-83. PMID 22127781 DOI: 10.1007/S11605-011-1781-6 |
0.385 |
|
| 2012 |
Narod SA, Salmena L. BRCA1 and BRCA2 mutations and breast cancer. Discovery Medicine. 12: 445-53. PMID 22127115 |
0.615 |
|
| 2012 |
Rodríguez AO, Llacuachaqui M, Pardo GG, Royer R, Larson G, Weitzel JN, Narod SA. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia Gynecologic Oncology. 124: 236-243. PMID 22044689 DOI: 10.1016/J.Ygyno.2011.10.027 |
0.616 |
|
| 2012 |
Han K, Nofech-Mozes S, Narod S, Hanna W, Vesprini D, Saskin R, Taylor C, Kong I, Paszat L, Rakovitch E. Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence Clinical Oncology. 24: 183-189. PMID 21958729 DOI: 10.1016/J.Clon.2011.09.008 |
0.368 |
|
| 2012 |
Cote S, Arcand SL, Royer R, Nolet S, Mes-Masson AM, Ghadirian P, Foulkes WD, Tischkowitz M, Narod SA, Provencher D, Tonin PN. The BRCA2 c.9004G>A (E2002K) [corrected] variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent. Breast Cancer Research and Treatment. 131: 333-40. PMID 21947752 DOI: 10.1007/S10549-011-1796-4 |
0.626 |
|
| 2012 |
Iqbal J, Ginsburg OM, Wijeratne TD, Howell A, Evans G, Sestak I, Narod SA. Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treatment Reviews. 38: 318-28. PMID 21775065 DOI: 10.1016/J.Ctrv.2011.06.009 |
0.605 |
|
| 2012 |
Metcalfe KA, Semple J, Quan ML, Vadaparampil ST, Holloway C, Brown M, Bower B, Sun P, Narod SA. Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction. Annals of Surgical Oncology. 19: 233-41. PMID 21674270 DOI: 10.1245/S10434-011-1828-7 |
0.72 |
|
| 2012 |
Narod SA. BRCA1 and BRCA2 in 2005. Discovery Medicine. 5: 50-4. PMID 20704923 |
0.56 |
|
| 2012 |
Narod SA. Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2. Women's Health (London, England). 1: 27-34. PMID 19803943 DOI: 10.2217/17455057.1.1.27 |
0.624 |
|
| 2012 |
Iqbal J, Narod SA. Choices for young women at intermediate risk of breast cancer Current Oncology. 19. DOI: 10.3747/Co.19.925 |
0.647 |
|
| 2012 |
García-Jiménez L, Gutiérrez-Espeleta G, Narod SA. Epidemiología descriptiva y genética molecular del cáncer de mama hereditario en Costa Rica Revista De Biología Tropical. 60. DOI: 10.15517/Rbt.V60I4.2159 |
0.668 |
|
| 2012 |
Rakovitch E, Nofech-Mozes S, Narod S, Hanna W, Saskin R, Tuck A, Sengupta S, Done S, Miller N, Youngson B, Paszat LF. Long-term rates of breast cancer in a population of women with ductal carcinoma in situ treated by breast-conserving surgery. Journal of Clinical Oncology. 30: 1123-1123. DOI: 10.1200/Jco.2012.30.15_Suppl.1123 |
0.425 |
|
| 2012 |
Jaworska-Bieniek K, Gupta S, Durda K, Muszynska M, Sukiennicki G, Jaworowska E, Grodzki T, Sulikowski M, Woloszczyk P, Wójcik J, Lubiński J, Cybulski C, Dębniak T, Lener M, Narod SA, et al. Microelements as risk factors for cancer of the lung and larynx Hereditary Cancer in Clinical Practice. 10: A2. DOI: 10.1186/1897-4287-10-S4-A2 |
0.402 |
|
| 2012 |
Huzarski T, Byrski T, Gronwald J, Górski B, Domagała W, Cybulski C, Sun P, Oszurek O, Szwiec M, Gugała K, Stawicka M, Morawiec Z, Mierzwa T, Janiszewska H, Kilar E, ... ... Narod S, et al. Impact of BRCA1 mutation on survival after early onset breast cancer Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S4-A19 |
0.559 |
|
| 2012 |
Huzarski TT, Górecka-Szyld B, Huzarska JJ, Psut G, Wilk G, Sibilski R, Cybulski C, Kozak-Klonowska B, Siołek M, Kilar E, Czudowska D, Janiszewska H, Godlewski D, Mackiewicz A, Jarkiewicz-Tretyn J, ... ... Narod S, et al. Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S4-A18 |
0.607 |
|
| 2012 |
Gronwald J, Byrski T, Lubinski J, Narod SA. Cisplatin in breast cancer treatment in BRCA1 carriers Hereditary Cancer in Clinical Practice. 10: A17. DOI: 10.1186/1897-4287-10-S4-A17 |
0.614 |
|
| 2012 |
Jaworska K, Gupta S, Durda K, Muszynska M, Sukiennicki G, Jaworowska E, Grodzki T, Sulikowski M, Woloszczyk P, Wójcik J, Lubiński J, Cybulski C, Dębniak T, Lener M, Narod SA, et al. Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium Hereditary Cancer in Clinical Practice. 10. DOI: 10.1186/1897-4287-10-S3-A7 |
0.433 |
|
| 2012 |
Cybulski C, Wokołorczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Dębniak T, Górski B, Blecharz P, Narod SA, Lubiński J. CHEK2 mutations as markers for high risk of breast cancer Hereditary Cancer in Clinical Practice. 10: A4. DOI: 10.1186/1897-4287-10-S3-A4 |
0.664 |
|
| 2012 |
Byrski T, Gronwald J, Huzarski T, Marczyk E, Blecharz P, Ashuryk O, Cybulski C, Zuziak D, Wiśniowski R, Godlewski D, Narod S, Lubiński J. Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S3-A3 |
0.513 |
|
| 2012 |
Cybulski C, Wokołorczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Dębniak T, Górski B, Narod SA, Lubiński J. The risk of breast cancer in women with a CHEK2 mutation Hereditary Cancer in Clinical Practice. 10: A5. DOI: 10.1186/1897-4287-10-S1-A5 |
0.602 |
|
| 2012 |
Byrski T, Huzarski T, Marczyk E, Blecharz P, Gronwald J, Ashuryk O, Cybulski C, Dębniak T, Zuziak D, Godlewski D, Kladny J, Lubinski J, Narod S. Why choose the treatment with cisplatin for BRCA1 breast cancers patients Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S1-A4 |
0.521 |
|
| 2012 |
Ertmański S, Metcalfe K, Trempała J, Głowacka M, Lubiński J, Narod S, Gronwald J. Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation Hereditary Cancer in Clinical Practice. 10: A14. DOI: 10.1186/1897-4287-10-S1-A14 |
0.657 |
|
| 2012 |
Lubiński J, Huzarski T, Jakubowska A, Gronwald J, Jaworska K, Muszyńska M, Sukiennicki G, Durda K, Cybulski C, Dębniak T, Tołoczko A, Oszurek O, Serrano-Fernandez P, Scott R, Narod S. Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet Hereditary Cancer in Clinical Practice. 10: A11. DOI: 10.1186/1897-4287-10-S1-A11 |
0.46 |
|
| 2012 |
Permuth-Wey J, Lin H, Tsai Y, Zhihua C, Chen YA, Barnholtz-Sloan J, Birrer MJ, Chanock S, Cramer DW, Cunningham JM, Fenstermacher D, Fridley B, Garcia-Closas M, Gayther SA, Gentry-Maharaj A, ... ... Narod SA, et al. Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study Cancer Research. 72: 2927-2927. DOI: 10.1158/1538-7445.Am2012-2927 |
0.333 |
|
| 2012 |
Tsai Y, Monteiro ANA, Phelan CM, Iversen E, Fridley BL, Chen YA, Chen Z, Permuth-Wey J, Jim HS, Vierkant RA, Cunningham JM, Barnholtz-Sloan J, August A, Sutphen R, Narod S, et al. Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibility Cancer Research. 72: 1649-1649. DOI: 10.1158/1538-7445.Am2012-1649 |
0.429 |
|
| 2012 |
Pal T, Bonner D, Akbari M, Narod S, Vadaparampil S. Abstract A34: How important is comprehensive rearrangement testing for BRCA mutations in African American women with early-onset breast cancer? Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-A34 |
0.605 |
|
| 2011 |
Passaperuma K, Plewes DB, Causer P, Hill KA, Messner SJ, Wong J, Jong RA, Wright F, Yaffe M, Ramsay E, Balasingham S, Verity L, Eisen A, Curpen B, Shumak R, ... Narod S, et al. Long-term results of the Toronto magnetic resonance imaging (MRI) breast surveillance study of women with BRCA1 or BRCA2 mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 542. PMID 28021507 DOI: 10.1200/Jco.2011.29.15_Suppl.542 |
0.624 |
|
| 2011 |
Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Wilson S, Moore MJ, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for pancreatic cancer in a high-risk cohort: A 7-year experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4045. PMID 28020520 DOI: 10.1200/Jco.2011.29.15_Suppl.4045 |
0.462 |
|
| 2011 |
Narod SA, Rodríguez AA. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes]. Salud PúBlica De MéXico. 53: 420-9. PMID 22218796 |
0.452 |
|
| 2011 |
Narod SA. Earlier age of onset in BRCA carriers-anticipation or cohort effect?: A Countercurrents Series. Current Oncology. 18: 257-258. PMID 22184484 DOI: 10.3747/Co.V18I6.973 |
0.615 |
|
| 2011 |
Narod SA. Should all women with breast cancer be tested for BRCA mutations at the time of diagnosis? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2-3. PMID 22147741 DOI: 10.1200/Jco.2011.37.6509 |
0.518 |
|
| Show low-probability matches. |